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PART I 
GENERAL INTRODUCTION 
1.1 The 'Gastrin' Hypothesis 
In 1905, Edkins put forward the concept of a 
humoral mechanism in the physiological control of 
gastric secretion. He suggested that food in the 
stomach led to the release of a substance from the 
mucosal cells into the blood stream through which 
it reached the gastric glands and stimulated them 
to secrete. The following observations were cited 
in support of this hypothesis: (Edkins, 1906). 
(a) Simple extracts of pig's or cat's antral 
mucosa, when given intravenously to anaesthesized 
cats, provoked gastric secretion. 
(b) These extracts also possessed vasode- 
pressor activity. 
(c) The active principle, which he termed 
'gastrin', was found in the antral and cardiac 
but not the fundic regions of the stomach. It 
resisted boiling and was therefore not a ferment. 
This report was followed by a series of in- 
vestigations by various workers, aimed at (a), 
elucidation of the physiological mechanism involv- 
ed and (b), further clarification of the nature of 
'gastrin'. 
Sokolov (1904, quoted by Babkin, 1928, 1934) 
worked on conscious dogs provided with a vagally 
innervated Pavlov pouch, a duodenal and a gastric 
fistula, and, in addition, a mucosal septum at the 
pyloro- duodenal junction, the myenteric nervous 
plexeuses remaining intact. Secretion from the 
Pavlov pouch occurred when meat extract was intro- 
duced via the gastric fistula into the 'obstructed 
stomach, but not when a similar ..extract was intro- 
duced into the duodenum. Gross (1906), working 
with a similar animal preparation but with the 
stomach divided at the junction between the fundic 
and antral regions instead, found that the reverse 
happened: meat extract given through the duodenal 
but not the gastric fistula excited secretion from 
the pouch. These findings were taken to indicate 
that the gastric glands were stimulated by an 
antral mechanism assumed to be nervous; the meat 
extract was supposed to have refluxed from the 
duodenum into the antrum in Gross' experiments. 
Similar results were also obtained by Krzyszkowski 
(1906) and Orbeli (1907). 
Edkins (Edkins and Tweedy, 1909) later pre- 
sented evidence in support of his own thesis. He 
showed that, when the fundic and antral regions of 
the stomach in anaesthesized cats were separated 
by a balloon ligated in position, the introduction 
of 0.2% HC1, meat extract, or 5% dextrose into the 
antral compartment for 1 -2 hours led to acid 
secretion from the fundus. Similarly, Savich and 
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Zeliony (1913) and Savich (1922 a) demonstrated 
definite secretogogue action of certain chemical 
agents when applied to the antral mucosa; and 
Zeliony and Savich (1914) and Savich (1922 b) 
further showed that distension of an isolated 
(vagally innervated) antral pouch was followed by 
secretion from the main stomach. This mechanical 
method of stimulation was eventually to play an 
important part in the final proof of the existence 
of gastrin. The earlier results of Fdkins were 
also confirmed by Maydell (1913) when he demon- 
strated that extracts of antral mucosa (but not 
pancreatic secretin, normal saline or extracts of 
fundic mucosa) excited gastric secretion when 
given subcutaneously to dogs with chronic _ gastric 
fistulae. 
However, opinions still differed as to the 
part played by nervous reflexes in contrast to 
this humoral mechanism. Orbeli (1907), for 
example, noted that when a vagally innervated 
Pavlov pouch was converted into a vagally dener- 
vated Heidenhain pouch, secretion from the pouch 
in response to a meal was markedly reduced, though 
histologically there was no atrophy of the gastric 
glands. He concluded that the secretory response 
depended in part on the existence of nerve con- 
nections. Furthermore, Zeliony and Savich (1911) 
reported that gastric secretion in response to 
irrigation of a vagally innervated antral pouch 
with secretogogues could be abolished by parenter- 
al atropine or prior application of cocaine to the 
pouch, strongly suggesting involvement of a nervou 
mechanism. 
Meanwhile, various attempts at isolation of 
the antral hormone had yielded different results. 
Popielski (1909, 1911, 1912) in a series of pub- 
lications ascribed the activity in Edkins' pyloric 
extracts to a non -specific principle (vasodilatin) 
presumed to be present in the extracts of various 
tissues, including the pyloric mucosa. At the 
same time, a gastric secretory excitant was found 
in simple extracts of the mucosa of the fundus, 
duodenum, ileum, jejunum, and oesophagus, as well 
as the liver, pancreas, brain and thyroid gland. 
(Ehrmann, 1911 -12; Emsmann, 1912; Tomaszewski, 
1913; Keeton and Koch, 1915; Luckhardt, Keeton, 
Koch and LaMer, 1919 -1920) so that the specificity 
of 'gastrin' and hence its hormonal status was 
seriously questioned. 
However, Dale and Laidlaw (1910 -1911) had 
suggested identity between vasodilatin and hista- 
mine; and when it was found later that histamine 
stimulated gastric secretion (Popielski, 1919; 
Keeton, Koch and Luckhardt, 1920), the confusion 
cleared considerably, but left behind the doubt 
as to whether 'gastrin' existed at all. It is 
fair to say, however, that Keeton, Koch and Luck - 
hardt (1920) had suspected that histamine and 
'gastrin' were different, since the former was mor 
toxic and produced more severe side effects. Ivy 
& Whitlow (1922) repeated Edkins' experiments 
(Edkins, 1909) but failed to confirm his findings. 
They therefore rejected the gastrin theory. Lim 
(1922 -23) however, the only investigator who re- 
peated Edkins' earlier work (Edkins, 1906) on 
pyloric extracts exactly as he had done them, con- 
firmed his results. In addition, he performed 
direct and indirect transfusion experiments from 
cats after a meal to fasting cats but failed to 
demonstrate 'gastrin' in the blood stream. He 
concluded that Edkins' 'gastrin' must be an 
artificial extraction product. 
In 1925, a series of 8 papers appeared, all 
bearing on the physiology of gastric secretion. 
Lim, Ivy & McCarthy (1925) recorded, amongst other 
results, that distension of a vagally denervated 
antral pouch (with sympathetic nerve supply intact 
led to acid secretion from the fundic portion of 
the stomach, and that the effect could be abolishe 
by atropine and topical procaine to the antral 
mucosa. This came close to proving the existence 
of a hormonal mechanism, but the results were un- 
fortunately interpreted as indicating that a 
nervous reflex mechanism was responsible, probably 
aided by vascular changes. 
Thus, 20 years after its first enunciation, 
the gastrin theory was severely challenged for 
want of both physiological and pharmacological 
evidence of its existence. It is clear, in retro- 
spect, that the circumstances arose from 
(1), the unfortunate confusion with histamine; and 
(2), misinterpretation of the experimental find- 
ings owing to lack of knowledge of the existence 
of 
(a) a nervous mechanism for the release of 
gastrin and 
(b) the possibility that both nervous and 
hormonal mechanisms may be involved at the 
same time, so that demonstration of the one 
does not necessarily exclude the other. 
It is of interest then to note that Edkins 
original observations, despite what has been said 
to the contrary, were essentially correct, though 
some of the conclusions drawn from them, when 
viewed in the light of present knowledge, were 
unwarranted. 
1.2. Proof of Existence of Gastrin 
The essential -elements constituting the 
final proof of existence of a hormone in general, 
and of gastrin in particular, have been well 
summarised by Grossman (1950). The evidence re- 
lating to gastrin will be considered as follows: 
(A) Physiological evidence 
(B) Pharmacological evidence: extraction 
and isolation of gastrin. 
(A) Physiological Evidence, 
In 1925, . in the 8th and last of the series 
of publications concerning the physiology of 
gastric secretion, Ivy and Farrell (1925) des- 
cribed the auto -transplanted gastric pouch- which 
was to become a classical method in the study of 
humoral mechanisms. A part of the stomach was 
transplanted in 3 stages to the mammary tissue of 
a bitch, thereby interrupting all nervous and 
vascular connections with the main stomach, the 
pouch deriving its blood supply entirely from the 
surrounding tissues. By this method, any stimu- 
lant reaching the pouch must travel by way of the 
circulation. It was found that the pouch secreted with 
a meal. 
Nevertheless, the presence of a humoral 
mechanism in the gastrointestinal tract did not 
provide conclusive evidence for the existence of a 
hormone, since absorbed food substances or products 
f digestion could also stimulate secretion. Kim 
and Ivy (1933) presented evidence suggestive of a 
hormonal mechanism when they showed that histamine - 
free liver extract was four times' more effective 
in stimulating gastric secretion when the extract 
was perfused through a gastric pouch than when the 
same amount was given intravenously, These results 
were later confirmed by Butler, Hands and Ivy 
(1943), Meanwhile, Gregory & Ivy (19 .1) made a 
classical study in dogs provided with an auto - 
transplanted gastric pouch, a vagotomized pouch 
of the remainder of the stomach (the main pouch), 
and an oesophago- duodenostomy. They confirmed the 
existence of a humoral mechanism by showing that 
the transplant as well as the main pouch secreted 
when the latter was irrigated with liver extract. 
They further observed that (1), prior application 
of procaine to the main pouch abolished the res- 
ponse from both pouches, and (2), procaine did not 
interfere with absorption of alcohol,and hence 
probably of other substances also, from the main 
pouch, nor did it influence the responses of the 
gastric glands directly. The procaine then pro - 
bably produced its effect by preventing the 
liberation of a hormone from the mucosa of the 
main pouch. This constituted the first strong 
evidence of the existence of gastrin, though the 
evidence was circumstantial. 
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Crucial evidence finally came from Grossman, 
Robertson & Ivy (1948) who demonstrated in dogs 
(1), that distension of a vagotomized antral pouch 
led to acid secretion from a transplanted fundic 
pouch; and (2) , that distension of a transplanted 
antral pouch caused similar secretion from a pouch 
of the main stomach which was vagally innervated. 
Since there was no question of the stimulating 
agent being absorbed, the humoral agent must have 
been a hormone. The evidence was conclusive. 
(B) Pharmacological Evidence: extraction and 
isolation of gastrin. 
The earlier confusion with histamine culmin- 
ated in the paper by Sacks, Ivy, Burgess and 
Vandolah (1932) when they isolated histamine from 
dog antral mucosa as the sole gastric secretory 
stimulant. However, they also noticed certain 
differences between the physico- chemical properties 
of histamine and crude gastrin; and the next year, 
Gavin, McHenry & Wilson (1933) found that the 
fundic mucosa contained more histamine than the 
antral mucosa, which did not seem to fit in with 
the site of origin of the humoral agent demon- 
strated earlier by Lim, Ivy and McCarthy (1925), 
These clues were overlooked. 
It is now obvious that this misconception of 
the possible nature of the antral hormone had 
caused failure in its isolation. Purification 
procedures were designed to remove all proteins 
(hence also gastrin) and retain smaller molecules 
(including histamine) rather than the reverse. 
In 1938, Komarov demonstrated for the first time 
that a protein fraction could be obtained from 
simple acid extracts of pyloric mucosa by tri- 
chloroacetic acid precipitation and 'salting out' 
procedures. The final material was histamine - 
free and stimulated acid gastric secretion when 
given intravenously or intramuscularly, but not 
subcutaneously, to conscious dogs or anaesthetize 
cats. This work started a new era in the purifica 
tion of gastrin, and later other investigators 
introduced various modifications of the method. 
Recently, Gregory (1926b) announced the isolation 
of gastrin in pure form. A more detailed review o 
this phase will be given in Section 3.1. 
The present status of gastrin can now be 
summarized: there is indisputable evidence of its 
existence as well as of its physiological role in 
the control of gastric secretion; its purifica- 
tion and final isolation have recently been 
achieved. 
1.3. The Physiological Role of Gastrin 
The available data related to gastrin and 
associated subjects have been critically reviewed 
by Grossman (1950), and Gregory (1962a) has sum- 
marized knowledge in the field to date with 
authoritative comments, and made valuable sug- 
gestions for future work. 
Site of Formation 
There is abundant evidence that the gastric 
antral mucosa is an important site of formation 
and release of gastrin (Lim, Ivy and McCarthy, 
1925; Grossman, Robertson & Ivy, 1948). The 
superficial part of the mucosa was found to con- 
tain more gastrin -like activity than the deeper 
parts (Lim, 1922 -23). The fundic mucosa, however, 
has not been shown convincingly to possess such 
properties. Distension of a fundic pouch alone 
caused secretion of acid (Lim et al., 1925) as 
well as pepsin (Grossman, 1960) but these find- 
ings alone do not constitute evidence for a hor- 
monal mechanism. Indeed, the pepsin secretion 
pointed strongly to a cholinergic mechanism 
since vagal stimulation is the only known strong 
stimulant of peptic cells, and gastrin released 
from antral pouches has been shown not to stimu- 
late pepsin secretion (Grossman, Woolley & Ivy, 
1944; Grossman & Slezak, 1950). 
The upper small intestine has been shown to 
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possess a humoral.mechanism for the stimulation 
of gastric secretion (Lim et al., 1925; Gregory 
& Ivy, 1941). According to Sirs (1953), the 
substance presumed to be released from the in- 
testine has the properties of a hormone, but 
there is no clear evidence that the hormone is 
gastrin. 
Mechanism of Release 
(a) Mechanical Stimulation - Local distension 
of the pyloric antrum has long been known to 
stimulate gastric secretion (Zeliony and Savich, 
1914). That this was due to gastrin release was 
suggested by Lim & Hou (1929) and proved by 
Grossman et al., (1948) . 
(b) Chemical Stimulation - A large variety of 
substances when applied to the antral mucosa will 
excite gastric secretion, e.g, food, peptone, 
glucose (Edkins & Tweedy, 1909), meat extract 
(Lim et al., 1925), protein hydrolysate, choline, 
and certain amino acids (Ivy & Javois, 1924 -25). 
But none of these have been shown definitely to 
act by causing gastrin release, for want of know- 
ledge of the exact constituent responsible for the 
stimulation. However, there is strong indirect 
evidence that liver extract (Kim & Ivy, 1933; 
Gregory & Ivy, 1941) and acetycholine (Robertson 
et al., 1950) do act, at least in part, by 
liberation of gastrin from the antrum, 
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(c) Vagal Stimulation - A possible link between 
nervous and humoral mechanisms controlling 
gastric secretion was first shown by Straaten 
(1933) and clearly put forward by Uvnas (1942) 
who suggested that vagal stimulation could (1), 
lead to gastrin release from the antrum and (2), 
condition the response of the gastric glands to 
it. Earlier investigators could not repeat 
Uvnas's findings (Jemerin, Hollander & Weinstein, 
1943 and others), but when the cause of failure 
was found in the phenomenon of inhibition of 
gastrin release by acid in the antrum, his results 
were amply confirmed (Woodward, Robertson, Fried 
& Shapiro, 1957 ;. Pe Thein & Schofield, 1959). 
(d) Local Nervous Mechanism - The probable 
existence of this mechanism could be inferred fro. 
the inhibitory effect of topical atropine and loca 
anaesthetics on gastrin release from a vagally 
denervated antrum by chemical and mechanical 
stimulation (Woodward, Lyon, Landor and Dragstedt, 
1954) and vagal excitation. Such a mechanism ma,/ 
provide a common 'pathway' to which all known 
stimuli converge to effect release of gastrin. 
There is so far no histological evidence of its 
existence. 
Inhibition of Release 
(a) Central - Elimination of the 'cephalic' 
phase of gastric secretion impaired digestion and 
gastric emptying (Pavlov, 1910, p. 99). This, 
however, could be accounted for by the absence of 
vagal effects; there is no evidence of active 
inhibition of gastrin release. 
(b) Gastric - There is ample evidence that 
acid in the gastric antrum inhibits gastric 
secretion (Sokolov, 1904; Wilhelmj, O'Brien & 
Hill, 1936) ay antagonizing the release of gastrin 
in response to chemical and mechanical stimuli 
(Oberhelman, Woodward, Zubiran & Dragstedt, 1952; 
Kim, 1955) and vagal stimulation (Pe Thein & 
Schofield, 1959) . The nature of this antagonism 
remains uncertain. It was probably effected 
without the intervention of a local nervous 
mechanism (Redford & Schofield, 1961), or the 
liberation of an anti- hormone (Longhi et al,, 
1957) though the contrary has been suggested 
(Harrison, Lakey & Hyde, 1956; Jordan & Sand, 
1957). The critical pH in the antrum at which 
this inhibition occurs has not been clearly 
established, but probably lies between pH 2 -5 
(Gregory, 1962a, p. 48). 
(c) Intestinal - A humoral agent, enterogas- 
trone, has been shown to originate from the duo- 
denum and upper jejunum and to produce the well 
known inhibitory effect of a fatty meal on gastric 
secretion and motility. (Feng, Hou & Lim, 1929). 
The evidence in support of its hormonal status is 
strong. It probably acts by antagonizing the 
effect of gastrin on the parietal cells 
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(Andersson, 1962) . 
Mode of Action 
The response of the parietal cell to gastrin 
is no doubt profoundly influenced by concomitant 
cholinergic excitation. Thus subthreshold doses 
of urecholine (carbamyl ß- methyl choline) 
potentiated the response of a transplanted or de- 
nervated fundic pouch to endogenous gastrin 
(Grossman, Robertson & Ivy, 1948; Gregory & Tracy, 
(1958, 1960a); distension of a denervated fundic 
pouch (thereby exciting the myenteric nervous 
plexuses) markedly increased its response to 
circulating gastrin (Grossman, 1961); and vago- 
tomy decreased the parietal cell response to 
histamine and pilocarpine but not urecholine 
(Oberhelman & Dragstedt, 1948; Hood and Code, 
1957, and others) . 
Atropine promptly reduced by 50% a near - 
maximal response of the parietal cells to injected 
gastrin (Gregory & Tracy, 1959b) and 'completely 
inhibited a weaker one. (Gregory and Tracy, 1960). 
These results were confirmed by Grossman & 
Gillespie, 1962. Komarov (1942b) and Blair, 
Harper, Lake, Reed & Scratcherd (1961), however, 
reported no inhibition by atropine with their 
gastrin preparations. These discrepancies pro 
.bably arise from differences in the gastrin 
extracts, in the methods of testing, and in the 
doses used. Local application of 1% atropine to 
 .4 
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the mucosa of a vagotomized fundic pouch, however, 
did not impair its response to endogenous gastrin 
(Woodward, Lyon, Landor & Dragstedt, 1954). Thus, 
the question whether the parietal cell can respond 
to gastrin in the complete absence of cholinergic 
effects remains unsettled. 
The Role of Histamine 
Histamine is distinct from gastrin. Its 
mode of action on the parietal cell is different 
(Grossman, 1961); the antagonism of its effects 
on the parietal cell by atropine is different 
(janowitz & Hollander, 1956; Gregory & Tracy, 1961 
and it differs chemically from gastrin. 
Babkin (1938, 19)j 1) had originally suggested 
a physiological role for histamine as the final 
mediator for all stimuli bearing on the parietal 
cell. Work on histamine contents of gastric 
juice from man and animals (Emmelin & Kahlson, 
19)111; Code, Hallenbeck & Gregory, 1947) yielded 
results compatible with Babkin's hypothesis but 
also explicable by other theories. The relevant 
data have been summarized by Code (1956). 
Furthermore, the response of the parietal cell to 
injected gastrin was not accompanied by detectable 
rise in plasma histamine (Gregory & Tracy, 1961) 
Blair et al., 1961), and histamine injected into 
the portal circulation could not survive passage 
through the liver in quantities adequate to 
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stimulate gastric secretion (Gregory & Tracy, 
stated by Gregory, 1962, p. 91). However, the 
possibility remains that, with various stimuli, 
histamine may be liberated in minute amounts in 
close proximity to the parietal cell thereby 
exciting secretion. 
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1.5 Biological Assay of Gastrin 
For want of more exact knowledge of the 
physical and chemical properties of gastrin, the 
hormone has hitherto been defined and measured 
solely in terms of its biological effect, which 
appears to be specifically that of stimulating the 
parietal cell to secrete hydrochloric acid. Thus 
all attempts at quantitative estimations of gas- 
trin activity have been expressed in terms of the 
acid secretion from the stomach of an experimental 
animal or man, in response to the presence of the 
hormone. 
The more important method for measuring 
gastrin activity, from the point of view of its 
bioassay, is that of estimating the acid secre- 
tion from part or whole of the stomach with or 
without vagal innervation in a conscious or 
anaesthetized preparation, in response to injected 
gastrin. Elkins (1906) employed cats under ether - 
chloroform anaesthesia and with their stomachs 
ligated at the cardiac end (including the vagi) 
and cannulated at the pyloric end. The cannula 
was connected to a reservoir and 20 -160 ml of 
saline introduced into the stomach under low 
pressure, retained there during the period of res- 
ponse, and then drained and tested for HC1 and 
pepsin contents. The gastrin extracts were in- 
jected intravenously every 5 -10 minutes. He state 
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that the basal secretion from these stomachs was 
negligible, so that any titratable acid in the 
gastric contents was taken as a positive response, 
and the activity of the extracts graded according 
to the amount of acid secreted. The phenomenon 
of 'exhaustion' of the animal with decreasing 
response to multiple doses was noticed. 
Keeton and Koch (1915) tested their gastrin 
extracts on conscious dogs with Pavlov pouches 
and gastric fistulae. The animals were starved 
for 36 hours, and their basal secretion was 
measured for 1 -2 hours before commencing the 
experiment. Gastrin extracts were injected 
intramuscularly since the intravenous route caus- 
ed reaction in the animal. Doses of 1 ml were 
usually used, and gastric secretion was collected 
in 15 minute samples and titrated for " free" and 
"total" acid. The pepsin content was also 
estimated. They recorded observations on the 
pattern of response and commented that while dogs 
with gastric fistulae were more sensitive and 
hence useful for detecting small amounts of gas- 
trin, those with Pavlov pouches were more 'stable' 
and less prone to accumulation effects of multiple 
doses. It was also noted that extracts active in 
the conscious dog produced no effects in etherized 
dogs or decapitated cats. The conscious dog pro- 
vided with various types of gastric pouches has 
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also been much used by Gregory and Tracy for 
testing their gastrin extracts. 
Lim (1922 -23), in his attempt to repeat 
Edkins' work (1906), used a slightly different 
technique. The stomach of an anaesthetized cat 
was similarly drained by a pyloric cannula, but 
the gastric secretion was obtained pure without 
gastric perfusion and led through a drop recorder 
so that any increase in rate of flow was noticed 
and taken as additional evidence of response to 
injected gastrin preparations. Lim & Ammon (1922- 
23) employed the same method in studying the 
difference in effect between injecting gastrin 
extracts into the systemic circulation in contrast 
to the portal circulation. 
Komarov in 1942 introduced a unit for the 
assay of his histamine -free gastrin extracts. He 
used cats and dogs under chioralose- urethane 
anesthesia. The oesophagus was ligated in the 
neck, and bilateral cervical vagotomy and sym- 
pathetomy were done. The pylorus was ligated and 
a cannula inserted into the fundic portion of the 
stomach. The pancreatic and bile ducts were also 
cannulated and the flow of the respective secre- 
tions studied at the same time. Several hours 
were allowed to elapse between the operation and 
the commencement of the assay, since considerable 
inhibition was noted during that period. Gastrin 
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extracts were injected intravenously. In another 
group of experiments conscious dogs each with a 
Heidenhain pouch, a gastric fistula, and 
oesophagotomy, were used, and the extracts given 
subcutaneously, intramuscularly, or intravenously. 
In both groups the doses were adjusted to give 
2 -7 ml of gastric secretion in 30 -90 minutes. The 
unit was defined as the amount of gastrin giving 
rise to 1 ml of strongly acid gastric juice. 
Munch- Peterson, Rönnow, & Uvnäs (1944-) worked 
on anaesthetized cats prepared in a manner similar 
to Komarov's, but introduced more exacting criteria 
for the method of administration of gastrin ex- 
tracts and assessment of response. Thus the actual 
assay started 1 hour after completion of the 
operative procedures. Gastrin extracts were dis- 
solved in physiological saline made slightly acid 
to Congo red and given intravenously at 0.4 ml/ 
minute for a period of 30 minutes. Gastric 
secretion was collected in 15 minute samples and 
the total volume collected in the hour from the 
start of the intravenous injection was taken as the 
response. The secretory rate was allowed to return 
to the baseline, usually in about 30 minutes, befo 
the next dose was given. The unit was defined as 
the amount of gastrin causing the flow of 1 ml of 
strongly acid gastrin juice in 6o minutes in a cat 
weighing 2 -3 kgm. Again, the doses were adjusted 
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so that the secretory rates fell between 5 -15 ml 
in 60 minutes; outputs of less than 2 -3 ml per 
hour were considered inconclusive. They also re- 
marked upon the phenomenon of 'exhaustion' in res- 
ponses and stated that it was species specific: 
thus cats become resistent to pig's gastrin but not 
to cat's gastrin. 
Jailing & Jorpes (1947), in a description of 
their version of Komarov's assay method, gave 
detailed consideration to the problems of variation 
of responses in the same animal and between animals, 
and suggested methods of overcoming them. Gastrin 
extracts were contained in 20 ml. of physiological 
saline and given intravenously over a period of 20 
minutes; gastric secretion was collected hourly 
and titrated for acidity with methyl red as 
indicator. The secretory unit was redefined as the 
amount of extract producing 1 ml of 0.1N HCi in 
the gastric juice in 1 hour. The authors stated 
that the correlation between acid output and dose 
was better than that between secretory volume and 
dose. 
The assay procedure started with a standard 
dose of gastrin extract adjusted to give 4 -6 ml 
of 0.1N HC1 in 1 hour. The next dose was doubled 
and given to test 'proportionality', thus introduc- 
ing the concept of the dose- response curve and its 
slope in the bioassay of gastrin. Subsegilent 
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doses were adjusted so as not to 'exhaust' the 
animal. The standard dose was repeated at the 6th 
or 7th dose to check possible alteration in res- 
ponsiveness. It was noted that, in Li-0 tests with 
the same dose given at the 1st and 7th injection, 
13 gave 'good correlation' in the magnitude of 
response, from which it was inferred that the 
responses to the doses given in between truly re- 
flected the size of the doses. Nine showed marked 
exhaustion and the remaining 18 had definite though 
reduced secretion with the 7th dose. In another 
110 experiments on doses of varying strength, it 
was found that the dose -response relationship held 
true in 60% of the experiments; most of the re- 
mainder showed exhaustion. When the same dose was 
given to different cats, the responses differed up 
to 9 -fold (2 -18 ml O.1N HC1 /hour). The authors 
therefore recommended using 5 or more cats for 
each assay. They also noted that impurities in th 
gastrin extracts reduced the accuracy of the assay 
and led to earlier 'exhaustion', and that doses 
producing responses of more than 10 -12 ml 0.1N HC1 
per hour invariably caused 'exhaustion' in the 
following hour. 
Ghosh (1956) and Ghosh & Schild (1958) per- 
fected a method of assaying gastric secretory 
stimulants and depressants which depended on per- 
fusion of the cavity of the rat stomach and 
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measurement of the pH of the perfusate. The metho 
was not designed specifically for assaying gastrin 
but has been modified and used for that purpose in 
the present work. It will be referred to in 
greater detail in Sections 2.1 and 2.2. 
Ferguson (1950) assayed mucosal extracts of 
human stomachs in the cat. The animal was put 
under light pentobarbital anaesthesia, and its 
body temperature was maintained at normal levels. 
Bilateral cervical vagotomy was done, the vagi 
were cut in the neck, and the stomach was then 
isolated by ligatures at the oesophagus and duo- 
denum and drained through a cannula. After 
collecting the basal secretion for an hour, doses 
bf,_éxtracts were injected intravenously over 20 
minute periods, and the acid secretion during the 
hour from commencement of infusion of the dose 
was taken as the response. A basal infusion of 
normal saline at 20 ml/hour was maintained 
throughout the experiment. Proportionalitÿ betwee 
dose and effect was best achieved with amounts of 
extracts in the range of 3 -8 g. of muco sa . Some 
assays were repeated 2 -3 times on the same or 
different animals and the results averaged. 
In 1961, Ùvnäs & Enás published a method of 
bioassay of gastrin with statistical control. The 
confirmed that responses varied within the sane cat 
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and between cats when under anaesthesia, but found 
better correlation between dose and effect in con- 
scious cats with gastric fistulae, and worked out 
a method for the assay of gastrin extracts against 
histamine as standard. Doses of either substance 
were contained in saline at pH 3 -4 and given intra- 
venously over 15 minutes at 0.24 ml /minute; the 
responses were estimated as the total acid (in mEq) 
secreted in one hour from the start of the gastrin 
infusion. The principle of the assay method lay 
in bracketting 2 identxal doses of gastrin with 2 
graded doses of histamine. Preliminary work had 
shown that the dose- response curve for the gastrin 
extract as well as histamine was linear over the 
range used in the assay. The same gastrin extract 
was used throughout the series, consisting of 7 
experiments in each of 3 cats. 
Certain strictly defined criteria were to be 
satisfied before any assay was considered valid. 
These concerned the basal secretion, the slope of 
the dose -response curve for histamine, and the siz 
of the response to the gastrin injections. The 
activity of the gastrin extracts wera expressed in 
Histamine Units (when 1 mg gastrin/kgm body weight 
/15 minutes elicit the same secretory response as 
0.001 mg histamine dichloride /kgm body weight /15 
minutes) and Secretory Units (the amount of gastri 
causing secretion of 1 ml of 0.1N HCl.; Results 
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given as Secretory Units /mg gastrin for comparison). 
Standard deviations were calculated and also ex- 
pressed as percentage of the mean value (the 
relative S.A.) for each group. It was found that 
within the same animal, the values for the relative 
S.A. were similar whether the results were given 
in Histamine Units (17% ) or Secretory Units (i)4Z ); 
but between animals, the relative S.A. for 
Secretory Units (2o7 ) became double the other 
(11% ), thereby confirming considerable variation 
in response between animals and suggesting parallel 
variation of sensitivity to histamine and the 
gastrin extracts. 
Harper, Blair & Reed (1962) independently 
devised a method for gastrin assay using the 
anaesthetized cat. The stomach was perfused with 
50 ml isosmolar glycine buffer at regular intervals, 
and the gastric secretory responses to injected 
stimulants estimated by titrating the perfusate 
back to its original pH with N /50 NaOH. A con- 
tinuous basal secretion was induced by injecting 
0.5 -1 mg of a standard gastrin (prepared by the 
method of Jorpes et al. (1952)) every 15 minutes. 
An unknown to be assayed was given to replace one 
of the standard doses, and the HC1 output in the 
subsequent 30 minutes was compared with the expect- 
ed amount had there been no substitution. At 
secretory rates of 0.05 -0.5 mE9/15 minutes, a 
linear relation existed between responses to the 
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Standard and the Test preparation when the acid 
output of the Test was within ± 50% of that of 
the Standard. A second gastrin preparation was 
assayed on 27 occasions in 7 cats and its activity 
found to be 75% (S.E. ± 1.97%) of the Standard. 
For cross reference, the arbitrary standard was 
assayed against histamine as the unknown, given 
under specified conditions; 1 mg of the Standard 
was found to be equivalent to 19.8 (S.E. 
± 
0.68)11g 
histamine base /kg body weight. 
In summary, then, Edkins' work (1906) was 
little more than qualitative, Keeton & Koch 
(1915) employed dogs with chronic gastric fistulae 
to eliminate the factor of animal variation, though 
the condition of the same animal in different tests 
could not be controlled. The unit of activity in- 
troduced by Komarov (1942) allowed of some stan- 
dardization but was largely nullified by the marked 
animal variation. Denervation of the stomach, 
however, removed a possible source of stimulation 
other than the injected gastrin and was an approach 
to achieving strictly level basal conditions during 
assays in the same animal. Restriction of size of 
the doses also helped to minimize accumulation 
effect and 'exhaustion'. It was Jailing and Jorpes 
(1947) who introduced some statistical rigour into 
the field. They also used dose -response relation- 
ships and suggested assays in groups of animals to 
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overcome individual variations. But the unit of 
activity, though improved, was still subject to the 
same criticism as that of Komarov. The rat pre- 
paration of Ghosh and Schild (1958) provided a 
means whereby multiple doses of a gastric secret- 
ory stimulant could be assayed in comparison with 
those of another. Four -point or even 6 -point 
assays could be carried out in a single preparation 
and Latin square designs completed in 2 or 3 
animals. The results analysed statistically by 
standard methods would detect and separate off any 
error due to animal variation, and in addition 
yield information concerning repression and 
parallelism of the dose -response curves and the 
error of the assay and hence its fiducial limits. 
Uvnàs & Emás (1961) were the first to employ a 
reference standard in the assay of gastrin, though 
the fact that histamine and gastrin act differently 
on the parietal cell would nullify the validity of 
the comparison (Gaddum, 1959) . Nevertheless, the 
strict attention paid to dose -response relation- 
ships, the avoidance of cumulative effects, and 
statistical analysis of the data fulfilled the 
essential requirements of modern bioassay tech- 
niques. 
Similar statements can be made concerning the 
method of Harper et al. (1962), but the intro- 
duction of an arbitrary standard with a composition 
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similar to that of the unknown has removed the 
major objection on pharmacological grounds. It is 
obvious that eventually all arbitrary standards 
must be assayed against the purified hormone as 





2. The Perfused Rat Stomach Preparation 
2.1 Introduction 
The rat has been much used for studying acid 
gastric secretion. It is readily available and 
easily handled. In order to empty the stomach be- 
fore use, Roe 8 Dyer (1939) starved them for 48 -72 
hours! coprophagia was overcome by putting each 
rat in a mesh -wire jacket. Gastric juice was col- 
lected from the anaesthetized animal by aspirating 
via a needle through the rumen of the stomach, the 
duodenum having been ligated. Contamination with 
saliva was prevented by a cotton plug in the threw 
Friedman (1943), in studying the effect of hista- 
mine on gastric secretion in the rat, starved them 
for 24-36 hours in wide mesh false bottom cages. 
Water was given ad libitum. Komarov et al. (1944) 
worked on rats with gastric fistulae and ligated 
pylorus. They recommended starvation for 48 hours 
with rats under 180 gm and 72 hours with larger on -s. 
Shay et al. (1945) first introduced the rat 
with ligated pylorus for acute experiments. 
Severe ulcerations of the stomach invariably 
occurred within a few hours. The potency of 
'anti -ulcer' agents were studied by noting their 
effectiveness in the prevention of these gastric 
ulcers. Madden et al. (1951) showed that 
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dehydration markedly reduced acid secretion, a 
point to be noted in starved rats which do not 
usually drink. Donald & Code (1952) supplied 0.4% 
saline ad libitum to rat starved for 72 hours. 
The gastric secretion was tapped by a pyloric 
cannula, but there was no apparent difference to 
the rate of secretion whether drainage was inter- 
mittent or continuous. Noordwijk & Aarsen (1954) 
employed a gastric lavage technique on an isolated 
stomach ligated at the oesophagus and duodenum and 
drained through a pyloric cannula. The stomach 
was washed out gently with 20 ml of warm normal 
saline at 30 minute intervals, and the washings 
titrated with 0.1N Na011. 
In 1958, Ghosh and Schild published a method 
for the quantitative study of gastric secretion 
in the rat, employing the technique of continuous 
perfusion of the gastric cavity. Rats were 
anaesthetized with urethane, and their body 
temperature was kept constant at 34 °C. by thermo- 
static control. The stomach was opened at the 
ruminal portion and washed clean of its contents. 
It was then perfused with warm N /4000 NaOH at a 
constant rate via oesophageal intubation, and the 
pH of the effluent was recorded continuously. The 
pH deflections with identical doses of secretory 
excitants and depressants were reproducible, and 
multiple doses could be tested in the same animal, 
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thereby eliminating variation between them. 
Application of the Latin Square designs provided a 
method for statistically valid assays with but few 
animals. 
Antonsen (1959) confirmed the importance of 
body temperature control when he used the dialysis 
bag method of studying gastric secretion in the rat 
Drugs were given intravenously and fluid was re- 
placed by the same route intermittently to combat 
dehydration. 
Lane et al. (1957) studied the dose- response 
relationship of histamine in rats provided with 
chronic gastric fistulae. They confirmed that 
rats have a high basal acid secretion, persisting 
even after 72 hours fasting; and they further 
showed that general anaesthesia, including that 
with urethane, depressed acid secretion. Thornton 
& Clifton (1959) adopted the method of Hunt and 
Spurrell (1951) of studying gastric emptying in 
man to experiments in the rat. A soft rubber 
catheter was passed down the oesophagus of the 
conscious animal and 7.5 ml of a sucrose test meal 
with phenol red was introduced, left for 45 minutes 
and then withdrawn and tit rated, and the acid out- 
put was calculated. 
The above account has summarized the various 
methods used in the rat. For the purpose of the 
bioassay of a gastric stimulant, however, the 
method of Ghosh & Schild (1958) provided obvious 
attractions in that most of the variables known to 
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affect acid gastric secretion in the rat were 
controlled, and the method of continuous perfusion 
allowed of reasonably complete collection of acid 
secreted and uninterrupted information on the 
secretory responses. It was therefore adopted for 
the present work. 
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2.2 The Technique 
Male albino rats of the Wistar strain were 
used throughout the experiments. Their body 
weight ranged from 180 gm to 320 gm with a mean 
of 232 gm. All rats were starved for 24 -48 hours 
before use. 
Anaesthesia 
General anaesthesia was induced by adminis- 
tration of urethane in 25% solution (w /v), the 
usual dose being 0.7 ml /100 gm body weight of the 
rat. Rats varied in their sensitivity towards 
urethane. Since it was desirable to have a con- 
stant level of anesthesia throughout each experi- 
ment, as well as a comparable plane of anaesthesia 
from one rat to another, a scheme was followed 
whereby the dose was adjusted to the individual 
animal. 
The body weight of the rat at the commence- 
ment of starvation was taken for calculation of 
the dose, since an average rat of 250 gm may lose 
up to 30 gm of its weight after 2 days without 
food, and the dose of urethane as estimated then 
may prove inadequate. Half of the dose thus cal- 
culated was given intraperitoneally. After 3 -4 
minutes, the animal was drowsy, with rapid 
shallow respiration and only corneal and pain 
withdrawal reflexes present. This indicated that 
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the dose was correct, and the remainder was then 
injected subcutaneously at 2 sites. If spontaneous 
movement of limbs, blinking, etc. persisted 5 
minutes after the intraperitoneal injection, the 
dose was considered to be too small and 0.2 ml 
was added subcutaneously. Absence of pain and 
corneal reflexes after the first dose indicated 
that the rat was unusually sensitive to urethane 
and 0.2 ml was subtracted from the remainder of 
the dose. The rat was usually fully under anaes- 
thesia in 30 -45 minutes. By then the respiration 
was slow (about 60 /minute) and mainly or wholly 
abdominal. Thoraci91' type of respiration was a 
bad sign and invariably meant a dying animal. 
Operative Procedure 
The rat was placed on a Rat Operating Stand 
(Model E 30, C.F. Palmer Ltd.). Its body tempera- 
ture was kept at 34 
± 
0.5 0C by a thermostatically 
controlled heating system consisting of (a), a 
table lamp with a 60 Watt electric bulb which 
was on continually and supplied heat and illumina- 
tion, and (b),a built -in source of heat in the 
operating stand, with a 40 Watt electric bulb. 
This was controlled, via a relay unit (Zecol Plug - 
in Relay Unit, G.H. Zeal Ltd.), by a contact 
thermometer set at 34 °C and introduced into the 
rectum of the animal. 
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A tracheotomy was first performed and a 
polythene airway inserted and ligated in position. 
The respiratory passages were kept open by suction 
with a polythene pipette to remove mucus when 
necessary. 
The abdomen was thenoopened by a transverse 
incision about an inch long and just touching the 
tip of the xiphisternal process, so that the end 
of the incision barely reached the costal margins. 
This provided a better exposure than a midline 
longitudinal incision. The lower edge of the 
liver was gently displaced upwards and the duoden- 
um thus exposed was brought to the surface with 
the aid of a seeker. Three ligatures were passed 
round the pyloro-duodenal j.znction as close to the 
gut wall as possible to avoid inclusion of any 
vessel running between the stomach and duodenum 
in the omentum. The first ligature served for 
traction. A small duodenostomy was made about one 
quarter of an inch from the pylorus, choosing an 
avascular spot, and a polythene cannula inserted 
towards the pylorus. The second ligature was then 
tied tightly midway between the duodenostomy and 
the pylorus. A pair of non -toothed forceps was 
applied to the duodenum at this ligature, thus 
holding the duodenum steady, while the cannula was 
gently pushed with a slight turn through the 
pylorus until the tip was just in the stomach. 
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This manoeuvre allowed passage of the cannula 
through the pylorus even if the latter was con- 
tracted, without undue damage to the duodenum. 
The third ligature was then tied at the pylorus. 
A soft rubber urethal catheter was passed 
down the oesophagus till the tip lay just in the 
ruminai portion of the stomach. The approximate 
length was equivalent to that between the teeth 
and the xiphoid process. The passage of the tube 
was usually accompanied by deglutition which 
facilitated the process. A ligature was then 
placed round the oesophagus at the neck. 
The stomach was next mobilized from its bed 
and delivered through the abdominal wound, as far 
as the ligaments would allow without undue stretch 
ing. This was achieved mainly by gentle traction 
on the relatively avascular ruminai portion. 
Handling of the glandular portion was avoided for 
such invariably resulted in trauma to the secretin 
mucosa with bleeding. The stomach was then washed 
by a slow stream of tap water introduced via the 
oesophageal tube from a reservoir held 50 cm above 
the rat. This was continued till the effluent was 
clear and all parts of the stomach especially the 
ruminai portion, were empty and collapsed. The 
stomach at the end of 1 -2 days starvation usually 
contained some food but was never full, so that 
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the washing out was not difficult. It was then 
returned into the abdomen: a small pad of cotton 
wool moistened with normal saline was placed 
against the ruminai portion to keep it collapsed 
during the experiment. This prevented any con- 
siderable collection of perfusate in this depen- 
dent portion. 
Perfusion of the stomach was carried out 
with 0.9% saline from a reservoir placed 200 cm 
above the rat. This head of pressure was reduced 
by means of a suitable length ofcapillary glass 
tube so that the final flow rate was constant at 
0.7 ml /minute. The saline was then led through 
several coils (length 60 cm) of thin polythene 
tubing (internal diameter .15 mm) placed between 
the rat and the table to warm the perfusate to 
the body temperature of the rat before finally 
introducing it through the oesophageal tube into 
the stomach. The gastric effluent from the pyloric 
cannula was led through a length of polythene 
tubing (24 cm long, 2 mm internal diameter) to a 
glass dropper placed 5 cm below the level of the 
rat to improve drainage of the stomach by siphon 
action. The fluid was collected in 10 minute 
samples, which measured 7 
± 
0.5 ml in the majority 
of cases. The variation in volume arose from 
differences in resistance in the different stomachs 
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and the occasional gastric peristalsic movement, 
but the volume tended to be constant during each 
individual experiment. 
The right femoral vein was exposed at its 
origin and a fine polythene cannula was inserted 
and ligated in position. A slow continuous basal 
infusion of 0.9% saline was started, using an 
electrically driven slow injection apparatus 
(Model 67, C.F. Palmer Ltd.) and adjusting the 
rate at 2 ml /hour. 
All exposed tissues were covered by pads of 
cotton wool moistened periodically with 0.9% 
saline. The whole operative procedure was usually 
completed in 30 -40 minutes and assay procedures 
could be started immediately afterwards. 
Titration 
The samples of gastric perfusate were titrat- 
ed against N /100 NaOH with phenolphthalein as 
indicator. The NaOH solution was stored in a 
polythene reservoir connected in close circuit to 
a 5 ml microburette, the tip of which was narrowed 
by a polythene tube drawn out at one end so that 
the drop size was about 0.15 ml. The whole system 
was protected from atmospheric carbon dioxide by 
soda lime. 
A simplified diagram of the set up of the 
animal preparation is shown in Fig. 1. 
Phenophthalein 
Warm 0.91. saline 
at 7ml / 10minutes 
100 Na OH 
10minute 
samples Gastrin in 1 ml by I.V. infusion 
in 15 minutes 




Rats of the same strain and sex were used to 
reduce the error of the assay. Urethane proved 
to be a suitable anaesthetic, (Ghosh, 1956), 
since a single dose provided constant anaesthesia 
throughout the experiment. The scheme described 
above ensured correct dosage and rapid induction 
of anaesthesia. The intraperitoneal route has not 
been found to affect acid gastric secretory res- 
ponses. 
The method of preparing the rat differed from 
that of Ghosh (1956) in several respects: - 
(1) Starvation of the rat and washout of 
the stomach without gastrostomy, thereby minimis- 
ing trauma to the stomach. It was important to 
starve the rat, since otherwise the stomach was 
usually packed with food which blocked the pyloric 
cannula and defied complete washout; a thoroughly 
clean stomach was essential for accuracy in the 
titration of the perfusate. Periods of starvation 
up to 48 hours did not impair the vitality of the 
animal as judged by the easy, regular respiration 
at the end of 8 -hour experiments and the unchanged 
pattern of gastric secretory responses. 
(2) Perfusion of the stomach with 0.9°0 
saline instead of dilute alkaline solution (Ghosh, 
1956) or a buffer solution (Rosenoer & Schild, 
1962), since the perfusate was to be titrated for 
acidity. 
(3) The rate of perfusion at 0.7 ml /minute 
was chosen arbitrarily, being fast enough to wash 
out all the acid secreted from the stomach without 
stasis, and slow enough to yield a volume con- 
venient for titration. 
(4) A basal continuous 0.9% saline infusion 
intravenously. It was felt that a large propor- 
tion of the weight loss during starvation was due 
to dehydration and loss of electrolytes, since it 
is well known that rats do not drink readily 
without food. The saline infusion served to 
correct this deficiency and to ensure a constant 
supply of Cl -, in addition to keeping the vein open 
for administration of gastrin extracts. A con- 
tinuous intravenous infusion of saline alone in 
the rat does not excite gastric secretion (Ghosh, 
1956). 
(5) Quantitative estimation of acid secreted 
from the stomach, instead of a continuous record- 
ing of changes in pH of the perfusate. This 
allowed of a simpler apparatus, and by collecting 
fractions of the perfusate in 10 minute samples, 
it was possible to follow closely the changes in 
the total acid output and hence the pattern of 
response to gastrin extracts. 
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3. PREPARATION OF GASTRIN EXTRACTS 
3.1 Introduction 
A brief review of the methods employed in the 
attempts to extract gastrin will be given. Tables 
summarizing the physiological and biochemical 
properties of these extracts are given in the 
Appendix (I(a) and (b)). 
The period under review can be conveniently 
divided into two parts separated by Komarov's 
classical work in the demonstration of a histamine 
free gastrin extract. The methods used during the 
first part yielded extracts all of which probably 
contained histamine; these extracts are therefore 
not considered in the table of properties. 
Edkins (1906), prepared simple extracts of 
hog gastric mucosa with cold and boiling water, 
5% dextrin or glucose, solutions of peptone or 
glycine, and 0.4% HC1. Of these, boiling water 
and glycine were found most effective, peptone and 
0.4% HC1 less so, and the rest doubtful. Pyloric 
and cardiac mucosa yielded about equal activity; 
fundic mucosa had none, but possessed considerable 
vasodepressor action. 
Keeton and Koch (1915), later joined by 
Luckhardt and later, made a series of studies on 
the extraction, distribution and mode of action of 
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'gastrin bodies' in various animals. Fresh 
tissues were extracted with boiling 0.4% HC1 
and the active fraction recovered by evaporation 
and tested in aqueous solution. Considerable 
activity was found in the mucosa of the pyloric, 
fundic and cardiac regions of the stomach, and to 
a smaller extent in duodenal mucosa. The oeso- 
phagus, pancreas and muscles were negative. There 
was a fall in blood pressure for 4 -5 minutes after 
each intramuscular injection of the extracts. It 
was also found ( Luckhardt, Keeton & Koch, 1920) 
that atropine antagonized secretory responses to 
injected histamine or gastrin extracts, the effect 
being proportional to the dose, and that the 
antagonism could be complete with smaller doses of 
gastrin extracts but never with histamine. Koch, 
Luckhardt & Keeton (1920) also extracted 'gastrin 
bodies' from gastric juice. Subsequent studies 
on the properties of the extracts led to the con- 
clusion that the 'gastrin bodies' were distinctly 
basic, closely similar to histamine, and might be 
a group of closely related peptamides. 
The work of Sacks et al. (1932) was aimed at 
isolation of histamine rather than gastrin. 
Komarov's (1938, 1942 a) classical work 
showed that a vasodilatin -free non -toxic extract 
could be made from hog antral mucosa which 
stimulated acid but not pepsin secretion. His 
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extraction procedures included saturation with 
NaC19 precipitation with 10% trichloroacetic acid 
(TCA) and fractionation with methanol. The 
potency of the final product, Purified Gastrin III 
was 2.5 - 4 mg /unit, Secreting being soluble in 
10% NaC1 (but not in 30%) and insoluble in 
methane, was separated from gastrin. 
Uvnäs (1943a) employed an abridged version 
of Komarov's method, obtaining crude extracts by 
boiling mucosal strips in N/10 HC1 and precipitat- 
ing with 10% TCA after partial neutralization, 
and finally drying the precipitate through acetone 
and ether. Doses equivalent to 2 -5 G mucosa from 
the cat or 5 -10 G mucosa from the hog given in- 
travenously over 30 minutes to anaesthetized cats 
illicited copious responses with maximal acidity 
of up to 180 mEq /litre. Activity was localized 
to the pyloric mucosa. 
Munch -Petersen, Rönnow & Uvnäs (1944) des- 
cribed in detail a modification of Komarov's 
method as applied to extraction of pyloric mucosa 
of cats and pig. Material from cats was dealt with 
in a manner identical with that of Uvnas (1943a) 
above. Pig mucosa was similarly extracted with 
boiling N /10 HC1. The filtrate was partially 
neutralized and the activity in it precipitated 
with 20% NaC1 and finally dried to yield 4 -7 G of 
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powder per stomach. This crude gastrin was 
further purified by (a) the tannic acid method or 
(b) the trichloroacetic acid method. The activ- 
ity of the crude powder, the tannic acid pre- 
cipitate, and the trichloroacetic acid precipitate 
as tested in the anaesthetized cat was about 6 mg, 
2.5 mg, and 2 mg /unit respectively. 
Uvnäs (1945a) introduced the isoelectric 
precipitation of the activity at pH 4 - 5.5 in 
place of the tannic method. Precipitation was 
complete at pH 4.4 and selective for gastrin at 
5 but with considerable loss of activity. 
Harper (1946) applied a modification of 
Mellanby's method for extraction of secretin to 
the gastrin problem. Mucosal tissue was extracted 
with alcohol; the active material was precipitat- 
ed by saturation with NaC1 or addition of bile 
salt; the latter was finally removed with alcohol 
Only extracts from the mucosa of the pyloric 
antrum and the upper small intestine were active. 
Jorpes, Jailing & Mutt (1952) devised a 
method of extraction with 95% acid methanol, 
suitable for handling large quantities of material 
The main steps included repeated isoelectric pre- 
cipitation at pH 7 and final dialysis to yield 
1.5 G of product per 10 kg mucosa. Its activity 
as tested in the anaesthetized cat varied, but was 
about 10 units /mg. 
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Gregory and Tracy in a series of papers 
(1959b, 1960b, 1961) described the development of 
a 3 -stage method for the extraction and purifica- 
tion of gastrin from hog antral mucosa. This 
method has been used for the preparation of crude 
and purified gastrin used in the present bioassay 
work, and a detailed 'flow sheet' of the method 
is given in Appendix II. 
The first stage of the method started with 
extraction of mucosal tissues with aqueous 
acetone containing 4 -5% TCA and subsequent removal 
of the acetone and TCA with ether to yield an 
aqueous extract. This was freed of a considerable 
portion of inert material by precipitation at 
pH 5 -5.5 and then at pH 8.5 in hot solution, when 
the active fraction was redissolved. Subsequent 
'salting out' by saturation with NaC1 and re- 
petition of alkaline precipitation yielded a clear 
supernatant which was then treated twice with TCA 
(4%) at 10 °C, and the precipitate containing the 
activity was dried through acetone and ether. Thi 
powder will be subsequently referred to as "Crude 
Gastrin" (Stage 1). The yield was 600 -700 mg/kgm 
mucosa, and amounts equivalent to 10 -20 gm mucosa 
provoked definite secretory responses from a dog 
when injected subcutaneously, intramuscularly or 
intravenously. 
The second stage of the method was aimed at 
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securing a gastrin solution largely devoid of 
inert material and suitable for column chromato- 
graphy. It consisted essentially of dissolving 
the crude gastrin powder in distilled water, 
making the solution strongly alkaline, and then 
precipitating the denatured protein at pH 8.5 
by addition of acetic acid in the presence of 80% 
acetone. The acetone was removed with ether, and 
the clear aqueous residue was ready for the final 
step in purification. 
In the third stage, the active fraction in 
the aqueous residue was adsorbed onto a CaPO4 gel 
column and then eluted by dilute Na2HPO4. A sharp 
peak of biuret -reacting material was associated 
with the front of the eluate and contained most 
of the activity. The final solution was clear and 
colourless with a pH of about 7. Amounts derived 
from 1 kg of mucosa contained approximately 0.5 mg 
total N. It could be stored deep frozen for months 
without loss of activity, and was highly potent. 
This fraction will be referred to later as 
"Purified Gastrin" (Batch A nr B). 
Grossman, Tracy & Gregory (1961) later pub- 
lished an abridged version of the above method 
which was employed in the extraction of tumour 
tissues. The extracts from both the primary 
pancreatic tumour and the secondary deposits in 
the liver of a patient with Zollinger -Ellison 
-48- 
Syndrome were active when given subcutaneously 
to dogs with Heidenhain pouches. This method has 
been applied to human tissues for quantitative 
recovery of gastrin -like activity in the present 
work. It is described in detail in a later 
section, and a 'flow sheet' of the method is also 
appended (Appendix III), 
Blair, Harper, Lake, Reed & Scratcherd (1961) 
reported a simple method for isolating crude 
gastrin from antral mucosa of man, pig, dog, and 
cat. The tissue was minced, homogenized in water 
and boiled for 10 minutes. After cooling, the 
major part of the residue was removed by centri- 
fugation and then prolonged filtration at 5 °C. 
The active fraction in the clear filtrate was 
precipitated by excess of acetone, washed, and 
dried, yielding a white powder (about 11 mg /gm 
mucosa) which has been stored for 4 years without 
loss of activity. 
Fletcher et al. (1961) and later the same 
group of workers (Anderson et al.,1961) described 
a 'somewhat novel' method for extraction of gas- 
trin, which differed from all other methods in 
two main aspects: (1) the pH of the extract at 
all stages was kept above 4, and (2) the tempera- 
ture never exceeded 40 °C. The mucosa was fixed 
in acetone, and digested in warm dilute aqueous 
NaOH (pH 10.5) . Subsequent procedures included 
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repeated precipitation of inert material at pH 
7 -8 and final recovery of the active fraction at 
pH 5. For bovine tissue, activity was found with 
the precipitate at pH 4 and 3 but not at 5. All 
precipitates were redissolved in dilute alkali 
(pH 11.0), dialysed against distilled water, and 
then dried. The yields varied between 0.5 -2.0 gm/ 
20 antra, and all possessed high activity. In an 
extensive study of the physico- chemical properties 
of the dialysed product, the authors found one 
main potassium- containing protein fraction (40%) 
and two other smaller protein -like fractions, and 
one non -protein fraction with 4 -7% phosphorus. 
The product after electrophoresis lost a con- 
siderable part of its activity and was less stable. 
Some differences were noted between bovine and 
porcine gastrin, e.g. in the latent period between 
a dose and the onset of response, and in the 
isoelectric point. 
Gregory (1962b) reported the isolation of 
gastrin in pure form, together with results con- 
cerning its amino acid components. 
In summary, then, it can now be seen that 
Edkins' (1906) simple extracts undoubtedly con- 
tained histamine, but the recent work of Blair et 
al. (1961) has shown that similar extracts did 
contain gastrin -like activity, quite apart from 
histamine. The alcoholic extracts of Keeton et 
al. (1915 -20) probably also contained both. 
Komarov's work (1938, 1942a,b) marked the turning 
point, and all subsequent methods yielded extract 
largely free of histamine. The procedures of 
TCA precipitation and 'salting -out' by saturation 
with NaC1 introduced by him formed the main stay 
of most methods thereafter. Uvnäs (1943a, 1945a) 
removed inert material by warming at alkaline 
solution and precipitating the active fraction at 
its isoelectric point of 4 - 5.5. Jorpes et al. 
(1955) obtained their active fraction from methan- 
ol extracts by precipitation at pH 7, and purified 
it by reprecipitation from distilled water and 
then dialysis. Then Gregory & Tracy (1961) in 
their three -stage method produced material largely 
devoid of inert proteins at the end of the second 
stage, after the combined efforts of isoelectric 
precipitation, 'salting out' with NaC1, TCA pre- 
cipitation, and then selective removal of denatur- 
ed protein by precipitation from strongly alkaline 
solution. The final fractionation from a CaPO4 
gel column yielded active material of high purity. 
Further extension of the method had apparently 
produced the hormone in pure form. Fletcher et al. 
(1961) worked on bovine and porcine tissues with a 
somewhat different approach and have studied the 




The Reference Standard 
The arbitrary reference standard employed in 
the present bioassay work was prepared by the 
method of Gregory & Tracy (1961). It was a freeze 
dried product of the eluate obtained at the end of 
Stage III of the method ( "Purified Gastrin ") . The 
eluate originally contained about 0.15% Na2PO4, 
and was at pH 7 -8. Studies by electrophoresis 
showed that there was one main active fraction 
with an isoelectric point of pH 5 -6, together with 
3 or 4 unidentified substances. Its protein con 
-tent was equivalent to approximately 200 pg of 
crystalline albumin /ml of the solution. When 
freeze -dried, 1 ml of the solution yielded 1100 pg 
of total solid, in the form of a white powder read 
ily soluble in distilled water or 0.9% saline. 
This powder was reconstituted with 0.9% saline to 
the original volume of the eluate and then diluted 
to appropriate concentrations before use. 
3.3 The Crude Preparations 
(a) "Crude Gastrin" (Stage I) 
This powder was obtained at the end of Stage 
I in the method of Gregory & Tracy (1961). It 
was usually light brownish, soluble in water or 
0.9% saline (aided by warming) . 
Before being tested in the rat, the solution, 
containing about 60 mg of powder in 10 ml of 0.9% 
-52- 
saline, was warmed to 70 °C; its pH was adjusted 
to 5 - 5.5 with 0.1 NaOH, and then to 8.5 with 
dilute NH4OH, allowing 10 minutes in between the 
steps. After a further 5 minutes, the solution 
was cooled and the precipitate removed by 
centrifugation. The clear supernatant was used 
for injection. 
(b) Crude Gastric Extract (human material) by 
the method of Grossman, Tracy & Gregory 
(1961). 
The intended quantitative study on the gas- 
trin -like activity in human tissues demanded that 
a suitable method of extraction be available where 
maximal recovery of activity could be achieved, 
even at the expense of the purity of the final 
product. The method employed by Grossman, Tracy 
& Gregory (1961) was attractive in that it was 
relatively simple but yielded extracts which were 
largely devoid of histamine. 
Mucosal tissues, obtained from operative 
specimens within 30 minutes of their resection, 
were cut in thin strips and extracted with 10 
volumes of 4% TCA in 90% acetone overnight. The 
brownish supernatant was collected the next morn- 
ing and the strips re- extracted twice,for four 
hours each, with 5 volumes of the acid acetone. 
All extracts were pooled, acidified (with 5 ml 
of 10 N HC1 per litre), and treated with ether. 
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The pH of the aqueous residue was love -i d to 3 
with 2N NaOH, traces of ether were expelled by 
gentle warming, and the solution then cooled to 
10 °C. TCA in solution was added slowly till a 
final concentration of 4% was achieved. The 
whitish precipitate was collected, resuspended in 
distilled water, and reprecipitated with TCA as 
above. This second precipitate was taken up in 
a suitable volume of 0.15 HC1, extracted once more 
with ether, heated to 70° - 80 °C, and brought 
through to pH 5 - 5.5 with 2N NaOH and 10 minutes 
later to pH 8.5 with dilute NH4OH. The precipi- 
tate was centrifuged off and the clear supernatant 
injected into the rat after suitable dilution. 
3.4 Discussion 
From a review on the methods of extraction 
and properties of gastrin, certain points emerge 
which are worthy of note. 
Firstly, gastrin is apparently a very stable 
compound, withstanding extremes of temperature 
(e.g. boiling for 30 minutes) and of pH (e.g. from 
less than 1 to 11 or 12). 
Secondly, despite the apparent multiplicity o 
methods for extraction of antral gastrin (though 
in fact they differed only in minor aspects), all 
products from any one animal have been found 
active in all animals tested. The usual experi- 
mental animals tested were dogs (conscious or 
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anaesthetized) and anaesthetized cats, and so far, 
there has been no report of one extract being 
active in 1 animal and inactive in another, 
though the magnitude of response varied. Thus, 
antral gastrin from the hog, dog, cat and cow has 
no species specificity as demonstrable by these 
biological tests. This assumption is further 
strengthened by the recent work of Monaco et al. 
(1961) who showed that antibodies to a hog gastrin 
extract could antagonize hog, dog, and human gas - 
trin:extracts. Although the gastrin extract used 
was not in pure form, and the resultant anti- 
serum contained a mixture of antibodies, the fact 
that a single anti -serum could antagonize the 
same activity in all 3 extracts from different 
sources warranted the conclusion that the active 
agents were identical or at least possessed 
identical moeities responsible for their action. 
There are, however, apparent contradictions 
to the above conclusions. Thus Uvnäs (1943a) 
observed that cats were more easily 'exhausted° 
when responding to hog antral gastrin than to cat 
antral gastrin; 'gastrin' from different sources 
and prepared by different methods have been report- 
ed as dialysable and non- dialysable; and Fletcher 
et al. (1961) noted that bovine and porcine gastrin 
had different isoelectric points. But before any 
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interpretation of these findings can be properly 
made, certain points need be considered: 
(1) All these observations were made on 
relatively crude preparations. As Gregory & 
Tracy (1961) suggested, the behaviour of 'gastrin' 
on dialysis might be influenced by its tendency 
to adsorb onto proteins also present, thereby 
giving a false impression of its molecular size. 
A similar effect may be produced on the apparent 
isoelectric point if other denatured proteins are 
also precipitated. 
(2) The mode of action of gastrin can be 
greatly influenced by such adsorption onto inert 
proteins (Gregory & Tracy, 1961). 
(3) The possibility remains that different 
crude extracts might contain, besides gastrin, 
other fractions which might stimulate or inhibit 
acid gastric secretion. 
It would appear, then, that unless more con- 
crete evidence from studies on purified prepara- 
tions points to the contrary, it is possible that 
gastrin is not species specific amongst dog, cat, 
hog and cow. 
Thirdly, in testing the biological effects 
of gastrin extracts and the influence of certain 
factors upon them (e.g. atropine, cholinergic 
excitation, etc.), it is important that conclusion 
be drawn only when the experimental conditions are 
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as near as possible to the normal physiological 
state in man under which it would act. In this 
context, the conscious dog should be used, for 
the following reasons: 
(1) It has been the most widely used animal 
in experiments based on the endogenous release of 
gastrin, upon the results of which conclusions hav 
been drawn and inferences made on the physiology 
of gastrin ih man. So far, there has been no 
known contradictions to these inferences by the 
sporadic data obtained direct from man. It would 
seem wise, therefore, to keep to the same animal 
species for tests on gastrin extracts. 
(2) The conscious dog is much easier to 
handle than other conscious animals for experi- 
mental purposes (e.g. cat, rat, etc.). Stress is 
to be laid on the conscious state, since anaes- 
thesia could possibly influence the response, 
both quantitatively and qualitatively. 
For the purposes of biological assay of 
gastrin, however, it is quite permissible to use 
anaesthetized animals, provided both the chosen 
standard and the unknown have been shown previous- 
ly to be active in the conscious dog; the 
assumption is made that the same active agent 
stimulated the dog as well as the anaesthetized 
animal to secrete. 
e 
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(3) Only one purified gastrin extract has been 
tested in man and found active (Gregory & Tracy, 
1961). The dog is the only experimental animal 
tested in the conscious state in which this same 
extract was active. 
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4. THE METHOD OF BIOLOGICAL ASSAY 
4.1 The Basal Secretion 
The anaesthetized rat produced a continuous 
basal acid gastric secretion which, under the con- 
ditions of the experiments, ranged from 1 to 2.5 
I,Eq /10 minutes in the majority of cases. The rate 
was relatively constant for hours when the rat was 
in a resting state, but it occasionally varied to 
a slight extent (e.g. up to 
± 
1 µEq /10 minutes) at 
the intervals between doses of gastrin extracts. 
4.2 The Pattern of Response 
The gastrin extracts were given by intravenou 
injection throughout the assay work, in order to 
avoid possible variation in the rates of absorptio 
with the other routes of administration. The 
pattern of responses was studied with the followin 
methods of intravenous injection: 
(a) Rapid Injection - The dose was contained in 
0.4 ml normal saline, injected within 20 
seconds, and flushed in by 0.4 ml of saline. 
An example of the response to a moderate dose 
of "Crude Gastrin" (Stage 1) is shown in Fig. 2. 
Acid secretion commenced in the first 10 minute 
period, rose to a peak in the second, and was 
usually down to the baseline in 40 -50 minutes. 










3 mg in 0.5 ml 
given I. V. in 20 secs. 
80 100 120 140 
TIME IN MINUTES 
CRUDE GASTRIN 
1.5 mg in 1 ml 
given I.V. over 15 mins. 
17- 
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TIME IN MINUTES 
Fig. 2. The pattern and magnitude of response 
to different modes of intravenous 
administration of a gastrin extract. 
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secretory response might not occur until the 
second 10 minute sample, would persist only in the 
third, and would be back to basal rates of secre- 
tion by the 4th. The peak rate of secretion de- 
pended on the dose and the sensitivity of the 
animal, but ranged from a barely detectable rise 
over the baseline to about 10 µEq /10 minutes. 
The same dose injected over a period of 5 
minutes showed a similar pattern of response. 
(b) Slow Infusion - The dose was contained in 1 
ml of normal saline and injected over a period of 
15 minutes. 
The response to a dose of the same "Crude 
Gastrin" (Stage 1) preparation but half of the 
size of the dose used in (a) above, is also shown 
in Fig. 2. It will be noted that the overall 
magnitude of response is similar in the two cases. 
In a typical example, the acid output was usually 
detectable at the first sample, increased steadily 
to a peak at the third, and then declined to reach 
the baseline again by the 7th or 6th sample. The 
peak response always fell on the 3rd sample, thoug] 
its magnitude varied considerably with the dose 
and the sensitivity of the animal and might reach 
16 µEq /10 minutes or higher. 
With identical doses of medium size given in 
succession to the same animal, the total acid out- 
put as well as the duration of response varied 
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from one dose to another, but their ratio remained 
relatively constant. After the 4th or 5th dose, 
however, all values including the ratio increased, 
presumably due to accumulation of effect (See Fig. 
4). 
With increasing doses, the effect was first 
seen in a rise in the acid output and in the 
ratio 'acid output /duration of response', with or 
without àn increase in the duration of response. 
When the dose reached 3 -4 times the threshold dose 
or above, all 3 parameters increased, but of these 
three, the ratio 'acid output/duration of response 
alone remained roughly proportional to the dose. 
This proportionality did not hold, however, when 
(i) the dose given was too large, so that the peak 
response was 12 i,Fq /10 minutes or higher, and (ii) 
more than 4 -5 doses were given to each animal, in 
which case the responses to doses after the fourth 
or fifth one were disproportionately large in 
relation to the dose. 
The patterns of response to equivalent doses 
of "Crude Gastrin" (Stage 1) and "Purified 
Gastrin" were similar. 
(c) Continuous gastrin infusion. 
In one experiment with a continuous intra- 
venous infusion of "Purified Gastrin" at a medium 
rate over a period of 21 hours (Fig. 3) the res- 
ponse rose sluggishly to a maximum by the end of 
the first hour, and then fluctuated considerably. 
I. V. INFUSION OF GASTRIN 
35- 
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TIME IN MINUTES 
140 160 180 200 
Fig. 3. Response to Continuous Intravenous Infusion 
of Gastrin. 
Yale rat, 232 g. 
Dose: "Purified Gastrin" Batch B, before 
freeze -drying, 0.01 ml /100 g body 
weight in 1 ml saline/15 minutes. 
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When the infusion was stopped, secretion declined 
rapidly and was back to the baseline within 30 
minutes. 
4.3 Measurement of Effect 
All doses of gastrin extracts were contained 
in 1 ml of normal saline at pH 7 and injected in- 
travenously over a period of 15 minutes. The study 
on the patterns of response with repeated identical 
doses revealed that the best criterion for assess- 
ment of response under the conditions of the ex- 
periment was the 'Mean Rate of Acid Secretion', 
expressed in µEq /10 minutes and defined as: 
Total acid output - estimated basal acid output (in ;_LEq. ) 
Duration of response (in periods of 10 minut =s) 
where Total acid output = acid output from baselin 
to baseline 
Estimated basal) Basal rate of acid secretion 
acid output ) - x duration of response. 




= -2-(mean rate of secretion befor 
the dose 
+ mean rate of secretion afte 
the dose. 
Each mean rate is based on 3 
consecutive similar readings 
(differing by less than 0.2 
pEq /10 minutes) 
Period between commencement of 
) - response to a dose and the nex 
baseline reading. 
An example of the calculation is given in Fig. 4. 
This method of calculation takes into con- 
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= 0.7 











,; --ti-- --^-- - - A 1 
20 40 60 80 100 120 140 160 180 200 220 240 260 280 
, 
300 
TIME IN MINUTES 
Fig. 4. The Measurement of Effect. 
Male rat, 280 gm. 
G = "Crude Gastrin" (stage 1) 0.5 mg /100 gm 
body weight in 1 ml given by IV infusion 
over 15 minutes. 
R = Estimated 'mean rate of acid secretion'. 




purpose of the assay, however, a 'resting' secre- 
tion which persisted at twice the original basal 
level (or higher) for more than 60 minutes, was 
taken as evidence of accumulation of the injected 
material and the assay of subsequent doses was 
therefore considered inaccurate. 
4.4. Dose -Response Relationship 
Sensitivity 
Rats varied in their sensitivity to gastrin. 
Differences of up to 8 -fold have been noticed, 
though most of them fell within the range of 4- 
f old. 
Response to Repeated Identical Doses 
Equal doses (0.5 mg /l00 g. body weight) of 
"Crude Gastrin" (Stage 1) were given to the same 
rat. Response to the first dose was irregular and 
usually smaller than the rest. This was true for 
histamine (Ghosh, 1956) . When subsequent doses 
were given in rapid succession, i.e. a second dose 
given as soon as the response to the previous one 
ceased, increasing rates of secretion were in- 
variably observed, commencing with the third or 
fourth dose. Prolonged waiting in between doses 
delayed but did not prevent this tendency of 
increasing responses, which eventually supervened 
with the fourth or fifth dose in any one animal. 
Contrary to most reports on experience with cats 
or dogs, the effect of accumulation of injected 
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gastrin extracts in the anaesthetized rat mani- 
fested itself in a progressive increase in acid 
output. The duration of response, however, was 
not prolonged proportionately. 
To overcome this interference of one dose 
with another, the following rules were observed: 
(a) The effect of the first dose was disregarded, 
though useful in giving a rough guide to 
the sensitivity of the rat. 
(b) After each dose, an interval was allowed 
which was equal to the period of response 
to that dose. 
(c) The size of the doses was limited so that the 
peak acid output /l0 minutes with any dose 
did not exceed 10 µEquiv. 
With these precautions, the estimated mean 
rates of acid secretion for the second, third and 
fourth, and occasionally the fifth dose were 
closely similar (Fig. 5). In the circumstances 
of the experiment, then, the number of doses to be 
assayed in each animal had to be limited to three. 
The results of experiments on 8 rats are 
shown in Table 1. There is no significant dif- 
ference between the means of the 'mean rates of 
acid secretion' of the 3 doses. The response to 
the first dose in each rat has been ommitted. 
8- 
G G G G 
fi Fi fi fi 
=19.4-1/2(1.9+1.5)x5 R_12-1-1/20-5+1.5) x3 R_13.65-1/2(1+1) x4 R_17.5-1/2(1.2+1.4)x4 
5 3 4 4 











I 1 1 I 11 1 1 i 1 1 
0 20 40 60 80 100 120 140160 180 200 220 240260 280 300 320 340 360 380 400 420 
TIME IN MINUTES 
Fig. 5. Reproducibility of Effect with Identical Doses. 
Male rat, 260 gm. 
G = "Crude Gastrin", (Stage 1) 0.5 mg /100 gm body 
weight in 1 ml given by IV infusion over 15 
minutes. 
R = Estimated 'mean rate of acid secretion'. 
The response to the first dose has been omitted. 
Responses to the second, third and fourth doses 
were comparable, but that to the 5th was increased. 
-64- 
TABLE I 
REPEATED IDENTICAL DOSES 
Il 
Crude Gastrin' (Stage I material) 
Each dose = 0.5 mg /100 Gm body weight of rat 
Dose Order Block 
Rat No. 2nd 
3rd 4th Total 
1 0.65 1.04 1.68 3.37 
2 0.85 1.50 1.20 3.55 
3 1.23 1.60 1.80 4.63 
4 1.20 0.60 1.00 2.80 
5 2.20 2.53 2.40 7.13 
6 1.64 1.42 1.42 4.48 
Column 7,77 8.69 9.50 25.96 
Total 
Mean 1.295 1.45 1.58 
Table of Analysis of Variance 
Source of Sum of Variance Variance P 
Variance d.f. Squares Ratio 
Between 2 0.249 0.125 1.32 > .2 
Columns 
Between 
Blocks 5 3.941 
0.788 8.34 .01-.001 
Error 10 0.944 0.094 
Total 17 5.134 
For Differences between the Mean Responses to the 
2nd and 4th doses: 
t - 
Sxl 






Responses to Graded doses 
"Crude Gastrin" (Stage 1). 
Initial. experiments were carried out with 
"Crude Gastrin" (Stage 1). Doses were given at 
3 levels A, B, and C, graded on a logarithmic 
scale so that C was double B and 4 times A. Any 
error arising from bias in dose order was controll 
by giving them in random order to a group of 6 rat 
so that all possible dose sequences were encounter 
ed within the group. The same rules as those for 
studying responses to identical doses were observe 
The results are represented graphically in Fig. 6 
and analysed in Table 2. It is evident that the 
individual log dose -response relationship is 
approximately linear in some animals only, and 
that in 2 animals, the response to dose A was 
greater than that to dose B. TJhen the results 
were analysed as a group, however, there was high- 
ly significant regression of response on log dose. 
"Purified Gastrin" Batch A freeze -dried. 
Because impurities in the gastrin extracts 
might influence the response, the same experiments 
were repeated with material obtained at the end of 
the last "stage of purification by the method of 
Gregory & Tracy (1961). The preparation was in 
crystalline form and derived from dessication of 
the active fraction of the eluate from the calcium 





RESPONSE RELATIONSHIP WITH GRADED DOSES, 












1.96 2.93 4.50 9.39 
1.80 3.38 4.40 9.58 
3.70 3.50 3.46 10.66 
3.55 2.20 5.04 10.79 
4.04 5.50 5.87 15.41 
2.54 3.45 4.25 10.24 
Column 
Total 
17.59 20.96 27.52 66.07 
Mean 2.93 3.49 4.59 
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Fig. 6. Response to Graded Doses. 
Dose A = 0.25 mg /100 mg body weight of rat. 
Dose B = 0.50 tt tt 9 9 II It 
tt tt It It tt It Dose C = 1.00 
Dotted line: mean of the responses. 
The letters at the end of each dose -response 
curve indicate the order of doses given in 




results (Fig. 7 and Table 3) showed that the dose - 
response relationship within the tested range was 
approximately linear in all 6 rats, and that the 
group analysed as a whole showed highly signi- 
ficant regression and little evidence of deviation 
from linearity. It also confirmed considerable 
variation between animals. 
"Purified Gastrin ", Batch B before freeze - 
rTing 
This second batch of material was in the same 
stage of purity as Batch A, but it was in 0.70% 
NaH2PO4 solution, i.e., the active fraction of the 
eluate from the calcium phosphate gel, without 
freeze -drying. Experiments similar to those des- 
cribed above were carried out with this material. 
The results, as shown in Fig. 8 and Table 4, again 
gave highly significant regression, though the 
Error Variance was almost twice and the Variance 
Ratio for 'regression' only about a fifth of the 
corresponding values for Batch. A. 
"Purified Gastrin ", Batch B, freeze- dried. 
A, second series of identical experiments was 
done with Batch B after freeze -drying. The ensu- 
ing data as presented in Fig. 9 and Table 5 showed 
that, in addition to the highly significant re- 
gression as obtained before, both the Error 
Variance and the Variance Patio for Regression 





RELATIONSHIP WITH GRADED DOSES 
"Purified Gastrin ", Batch A, freeze- dried. 
Rat Number 
& A B C Block 
Dose Order Total 
(1) A,C,B 1.60 2.44 3.70 7.75 
(2) A,B,C 1.20 2.43 3.22 6.85 
(3) B,C,A 1.25 2.04 3.51 6.80 
(4) B,A,C 2.00 3.40 4.70 10.10 
(5) C,B,A 0.60 2.35 3.70 6.65 
(6) C,A,B 1.35 2.80 3.30 7.45 
Column 
Total 
8.00 15.46 22.13 45.59 
Mean 1.33 2.59 3.69 
Table of Analysis of Variance 
Source of 
d f. Variance . 
Sum of 
Squares 
Variance Variance P 
Ratio 
Regression 1 16.638 16.638 218.6 <.001 
Deviation 
from 
Regression 1 0.018 0.018 0.237 N.S. 
Between 
Columns 





2.851 0.57 7.5' 1 5 < .00s 
Error 10 0.761 0.076 












3.7 2.0 2.3 
LOG DOSE/100g B. W. 
Fig. 7. Response to Graded Doses. 
Dose A = 5µg /100 gm body weight of rat. 
Dose B = 10 n tt It It It tt 
Dose C = 20 It It II It It tt 




GRADED DOSES RELATIONSHIP WITH 
"Purified Gastrin ", Batch B, before freeze- 
drying. 
Rat Number 
& A B C Block 
Dose Order Total 
(1) A,C,B 1.79 2.75 4.43 8.97 
(2) C,.A,B 1.94 2.65 3.35 7.94 
(3) B,C,A 2.23 3.05 3.91 9.19 
(4) B,A,C 2.60 2.70 3.26 8.56 
(5) A,B,C 1.23 2.20 2.90 6.33 
Tocan 9.79 13.85 17.85 40.99 
Mean 1.96 2.67 3.57 
Table of Analysis of Variance 
Source of 
d.f. 
Si m of Variance Variance P 
Variance Squares Ratio 
Regression 1 6.496 6.496 46.4 <:.001 
Deviation 
from 
Regression 1 0.03 0.03 0.216 N.S. 
Between 
Columns 2 6.526 3.263 2.3.3 < .001 
Between 
Blocks 
4 1.756 0.439 3.1 .05 
Error 8 1.110 0.139 
Total 14 9.392 
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LOG DOSE/100g B. W. 
Fig. 8. Response to Graded Doses. 
µg }100 gin body weight of rat. . 
lt 
et It lt It lt it 
Dotted line: mean of the responses. 
Dose A = 5.5 osB = 11.0 




DOSES RELATIONSHIP WITH GRADED 
"Purified Gastrin ", Batch B, Freeze- dried. 
Rat Number 
& A B C Block 
Dose Order Total 
(1) A,C,B 1.70 2.90 3.74 8.34 
(2) B,A,C 2.93 3.57 4.36 10.86 
(3) C,A,B 2.10 3.30 4.51 9.91 
(4) B,C,A 1.60 2.56 3.63 7.79 
(5) C,B,A 1.85 3.10 4.43 9.38 
(6) A,B,C 2.30 3.68 5.11 11.09 
Column 
Total 
12.48 19.11 25.78 57.37 
Mean 2.08 3.185 4.3 
Table of Analysis of Variance 
Source of 
d.f. 
Sum of Variance Variance P Variance Squares 
Ratio 
Regression 1 14.7408 14.7408 233.2 <.001 
Deviation 
from 
Regression 1 0.0001 0.0001 0.0016 N.S. 
Between 
Columns 
2 14.7409 7.37 116 <.001 
Between 
Blocks 
5 2.936 0.587 92.8 <.001 
Error 10 0.632 0.0632 
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LOG DOSE /100g B. W. 
Fig. 9. Response to Graded Doses. 
Dose A = 5.5 µg/100 gm body weight of rat. 
Dose B = 11.0 tt It tt tt It tt 
Dose C = 22.0 tt n tt It tt tt 




Hexamethonium Basal Infusion 
To investigate the effects of blocking the 
vagal impulses on gastric secretion, with a view 
to minimizing possible variations on the 'basal' 
state during the experiment, Hexamethonium bromide 
was given as follows: 2 mg intravenously followed 
by a continuous infusion at the rate of 2 mg/hour 
throughout the experiment in 6 rats. Batch B 
"Purified Gastrin" before freeze- drying was given 
again in graded doses. No appreciable effect was 
noticed on the basal level of secretion or the 
magnitude of responses to the injected gastrin. 
The results are shown in Fig. 10 and Table 6. 
Regression was highly significant, but the Error 
Variance was raised. 
Bilateral Cervical Vagotomy 
A further group of 6 rats was studied in the 
following manner: both vagi were exposed and 
dissected out at the neck at the beginning of the 
operative procedure and left till one hour later 
when they were cut without further handling to 
avoid stimulation. This procedure invariably 
produced marked changes in the respiration, which 
became much deeper and entirely abdominal in type, 
and the rat as a whole showed gross dyspnoea. 
Most of the rats died within 5 hours after vago- 
tomy. 







RELATIONSHIP WITH GRADED 
Batch B, before 
of Hexamethonium bromide. 
Rat No. & 
Dose Order A B C Block 
Total 
(1) B,A,C 2.40 3.62 4.61 10.63 
(2) A,C,B 1.80 2.10 2.40 6.30 
(3) B4O,A 1.90 3.35 4.35 9.60 
(4) C,B,A 2.07 2.92 4.25 9.24 
(5) A,B,C 2.76 3.20 3.53 9.49 
(6) C,A,B 1.36 2.20 4.00 7.56 
Column 
Total 
12.29 17.39 23.14 52.82 
Mean 2.05 2.9 3.86 
Table of Analysis of Variance 
Source of Sum of 
Variance d.f. Squares Variance Vantiige P 
Regression 1 9.81 9.81 44.7 < .001 
Deviation 
from 
Regression 1 0.01 0.01 0.0455 N.S. 
Between 
Columns 2 9.82 4.91 22.4 < .001 
Between 
Blocks 5 4.15 0.803 3.7 .05 -.01 
Error 10 2.195 0.22 
Total 17 
PURIFIED GASTRIN B BEFORE FREEZE- DRYING 
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T. 54 3 84 2 14 
LOG DOSE/100 g B. W. 
Fig. 10. Response to Graded Doses. 
Dose A = 0.0035 nil gastrin solution ) in 0.7 ml 
(_ 3.5 pg gastrin) /100 gm body weight) ) saline given1 
Dose B = 0.0070 ml gastrin solution ) by IV in- 
(_ 7.0 pg gastrin) /100 gm body weight) ) fusion over 15 minutes. 
Dose C = 0.0140 ml gastrin solution ) 
(_ 14.0 µg gastrin) /100 gm body weight)) 
(7) 
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The pattern of response to injected gastrin 
was also altered. Sensitivity increased consider- 
ably so that a third or half the usual dose would 
produce effects similar to the full dose in 
other animals. Prompt returns to the baseline 
kept the duration of responses short. The calcul- 
ated mean rates of acid secretion showed good 
correlation with log dose (Fig. 11, Table 7). The 
results of analysis of the data were similar to 
those from animals without vagotomy. 
Crude Gastrin Extract (Human Material) 
Since the subsequent application of this 
method of bioassay entailed a comparison between 
the arbitrary standard and crude gastrin extracts 
of human material prepared by the method of 
Grossman, Tracy & Gregory (1961) described in 
Section 3.32, the dose -response relationship of a 
random sample of these crude extracts was examined 
The doses were adjusted to give responses similar 
in magnitude to those with "Purified Gastrin ". 
above. The results are shown in Fig. 12 and Table 
8. It will be noted that the dose -response curves 
are all approximately linear, and that the re- 
gression was highly significant. The Error 
Variance was similar to that of "Purified Gastrin" 
Batch B without freeze- drying. 
In conclusion, then, the above preliminary 







RELATIONSHIP WITH GRADED DOSES 
Batch B, before freeze 
Vagotomy, 
Rat No. & 
Dose Order A B C Block Total 
(i) B,A,C 1.60 2.55 3.20 7.35 
(2) B,C,A 1.70 2.43 3.80 7.93 
(3) A,B,C 1.40 2.26 3.30 6.96 
(4) C,B,A 1.13 1.50 1.84 4.47 
(5) A,C,B 1.75 2.57 3.33 7.65 
Column 
Total 
7.58 11.31 15.47 34.36 
Mean 1.52 2.26 3.1 
Table of Analysis of Variance 
Source of Sum of Variance 
Variance d.f. Squares Variance Ratio P 
Regression 1 6.225 6.225 77.8 <.001 
Deviation 
from 
Regression 1 0.006 0.006 0.0741 N.S. 
Between 
Columns 2 6.231 3.12 39 <.001 
Between 
Blocks 4 2.577 0.644 8.05 .01 -.00L 
Error 8 0.61.8 0.081 
Total 14 9.456 
PURIFIED GASTRIN B BEFORE FREEZE - DRYING 
BILATERAL CERVICAL VAGOTOMY 






3.24 3.54 3.84 
LOG DOSE /100 g B. W. 
Fig. 11. Responses to Graded Doses. 
Dose A = 0.00175 ml gastrin solution ) 
(= 1.75 pg gastrin) /100 gm body weight)) in 3 ml. 
Dose B = 0.0035 ml gastrin solution 
) saline given 
(= 3.5 µg gastrin) /100 gm body weight) ) 
by IV in- 
fusion over 
Dose C = 0.0070 ml gastrin solution ) 15 minutes. 
( 7.0 pg gastrin)/100 gm body weight) ) 
Dotted line : mean of the responses. 
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TABLE 8 
DOSE RESPONSE RELATION`TSHIP WITH GRADED DOSES 
Crude Gastrin Extract (by method of Grossman, 
Tracy & Gregory) 
Rat No. & 
Dose Order A B C Block Total 
(1) A,B,C 1.30 2.24 3.36 6.90 
(2) C,B,A 0.50 1.91 3.90 6.31 
(3) A,C,B 2.10 3.70 4.50 10.30 
(4) B,A,C 2.07 3.10 4.4o 9.57 
(5) C,A,B 0.70 1.32 2.30 4.32 
(6) B,C,A 0.80 1.32 2.25 4.37 
Column 7,47 13.59 20.71 41.77 Total 
jean 1.245 2.26 3.45 
Table of Analysis of Variance 
Source of Sum of Variance 
ariance d.f. Souares Variance Ratio P 
*egression 1 14.6081 14.6081 103.0 
Deviation 
from 
Regression 1 0.0278 0.0278 0.196 
Between 
Columns 2 14.6359 7.318 51.6 
Between 
Blocks 5 10.690 2.14 15.1 

















CRUDE GASTRIN EXTRACT 








I 1 I 
1.0 1.3 1.6 
LOG DOSE/100g B. W. 
Fig. 12. Responses to Graded Doses. 
Extract of human antral mucosa. 
Dose A -. 0.1 ml /100 gm body weight of rat. 
Dose B = 0.2 tt tt tt rt tt tt 
Dose C = 0.4 tt It tr It n It 
Dotted line: mean of the responses. 
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conditions and method of assessment of response, 
the log dose :response relationship remained linea 
over the given range for both the crude and the 
purified gastrin preparations. To compare the 
accuracy of these estimations, however, the 











Batch A 0.076 0.237 
"Purified Gastrin" 




Batch B freeze - 
dried 
0.063 0.0016 
Hexamethonium infusion 0.22 0.045 
Bilateral vagotomy 0.081 0.074 
Crude Gastrin Extract 0.142 0.196 
(Human Material) 
It will be noted that the Variance Ratio for 
'Deviation from Regression' and the Error Varianc 
with the freeze -dried "Purified Gastrin ", Batch B 
were the smallest, being about 1/300 and 1/9 res- 
pectively of the corresponding values for "Crude 
Gastrin" (Stage 1). 
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4.5 The Procedure in the Bioassay - The Balanced 
Incomplete Block Design 
In the design of a method of biological assay, 
it is desirable to arrive at one which would pro- 
vide information concerning: 
(a) the significance of linear regression and of 
deviation from parallelism of the dose - 
response curves of the Standard and the Test 
preparation. 
(b) variability due to differences between blocks 
and between different positions in each block 
(order of administration of treatments)) and 
the consequent effect on the potency estimate 
and 
(c) the error of the assay, and hence the fiducia: 
limits of the estimate. 
The simplest method answering to these re- 
quirements is the 4 -point assay with construction 
of 4 x 4 Latin Square Designs. However, the 
strict limitation of three doses to each rat ex- 
cluded this possibility. The difficulty was over- 
come by application of the Balanced Incomplete 
Block Design of Youden (1937 -8, 1949 -41) . The 
statistics of the design and its application to 
this problem have been worked out by Mr. David 
Colquhoun with assistance from Dr. D.J. Finney. 
A simplified account of the mathematics involved 




There are many possible balanced incomplete 
block designs, but the pattern employed in this 
assay method had 12 treatments (doses) in each 
square, (i.e. group of 4 rats). An example is 
shown in Table 9. Each of the 4 rats received 3 
TABLE 9 
An Example of a Balanced Incomplete Block 
Design 
Rat No. Dose Order 
1st 2nd 3rd 
1 HS LS HT 
2 HT LT LS 
3 LS HS LT 




LS HT LT 
i x x x 
2 x x 
3 x x 




HS = High dose of the standard 
LS = Low dose of the standard 
HT = High dose of the test preparation 
(Unknown) 
LT = Low dose of the test preparation 
treatments, which were so distributed that each 
column, i.e., the four first, second or third 
doses in the 4 rats (see Table 9(a)), was formed 
-79- 
by a complete replicate and that no repetition of 
treatment occurred in any rat. Table 9(b) shows 
the same block in which the doses have been re- 
arranged according to their size. It can be seen 
again that each block consists of 3 complete 
replicates of 2 graded doses (i.e. a 'high' and a 
'low' dose) each of the Standard and the Test 
preparation. The 'high' doses were double the 'low' 
ones, and their sizes were adjusted to that 
the magnitude of the corresponding responses were 
similar. One hundred and forty -four different 
blocks of 12 treatments can be designed when tak- 
ing into account variation in the order of animal 
used. Statistical analysis of results obtained 
gave all the necessary information as listed at 
the beginning of this section. 
The smallest 'balanced' block comprised 4 
rats, but greater accuracy of estimation could be 
obtained with more blocks and pooling of the 
results. 
4.6. Fiducial Limits of the Estimate 
In order to determine the error of the assay 
method, the same "purified Gastrin" (Batch B, 
freeze- dried) in different known concentrations 
was used as both. Standard and Test and assayed 
aginst itself. Three blocks of 4 rats each were 
4.7 
- 8o - 
used and the results analysed in single blocks, 
in combination of 2 blocks, and all 3 blocks to- 
gether (The data for each block are shown in 
Table 10, and the results of analysis of these 
data in Table 11). The detailed calculations for 
a single block and the pooling of all 3 blocks 
will be given in Appendix IV. All the fiducial 
limits of the estimate included the true potency. 
For single blocks of 4 rats, the fiducial limit 
ranged from about + 15% to about +203. When 2 
blocks were combined, it was about 1-103 to about 
1-203. With 12 rats (3 blocks) , it was down to 
'112%. 
Discussion 
The observation that gastrin extracts were 
much more effective when given by slow intra- 
venous infusion than when the same amount was 
given rapidly intravenously in the rat, confirmed 
the findin;s of Gregory & Tracy (1961) in dogs 
and man, and those of Blair et al. (1961) in cats. 
Sensitivity of the assay was thereby increased, 
with corresponding reduction in dosage and risk 
of accumulation of effect, and hence its choice 
as the method of administration in the assay. 
The pattern of response limited the assess- 
ment of response to the only suitable measurement 
of 'mean rate of acid secretion'. A number of 
others, including the peak secretory rate and the 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































specified time limit, have been found unsatis- 
factory. 
The study on the effects of purity of the 
of 
extract andhblocking of vagal influence on the 
dose -response relationships have led to the con- 
clusion that the freeze -dried purified gastrin 
extract of Gregory & Tracy would form a suitable 
arbitrary standard for the assay of gastrin 
activity in the rat preparation. Hexamethonium 
infusion and bilateral vagotomy did not improve 
linearity of regression or reduce the error of 
the assay. 
The balanced incomplete block design of 
Youden has hitherto been largely applied to 
agricultural problems, but its use in the present 
assay has been demanded by the restriction of the 
number of treatments in each block. The design 
of the block and the statistical analysis of 
data, however, have yielded at least as much in- 
formation as would have been available from other 
designs with the same amount of data. The 
fiducial limit of the assay improved with more 
blocks so that the fiducial range with 12 rats 
was about half of that with 4 rats. When balancin 
economy of time with gain in accuracy of the assay 
however, it was decided to use single blocks of 4 
rats for each assay. 
-8.- 
All subsequent assays are based on the 
assumptions (1) that the effect produced by the 
active agent in the Test preparation (human tissue 
extracts) is identical with that in the Standard, 
(2) that this agent is the only one in the Test 
preparation which is capable of stimulating acid 
secretion, and (3) that all other impurities in 
the extracts are inert. Whether these assumptions 
are justified or not remains to be seen. 

-85- 
REPRODUCIBILITY OF THE EXTRACTION PROCEDURE 
OF GROSSMAN, TRACY & GREGORY (1961). 
To test this aspect of the method, 4 -5 hog 
stomachs were obtained within 1 hour after death, 
washed clean of their contents, everted, and fixed 
in 5i' TCA, then brought back to the laboratory. 
The pyloric mucosa was stripped off, cut up into 
small pieces (about 4 x-4- ), thoroughly mixed, 
and then redivided into equal portions of 30 gm. 
each. These were extracted separately at the same 
time by the method of Grossman, Tracy & Gregory 
(1961) as described in Section (b) above, until 
the stage of the aqueous residue after removal of 
the TCA and acetone. These squeous portions were 
all kept deep frozen, and one portion was then 
taken each day and brought to the last stage of 
extraction in an identical manner. The final 
solution was made up to 12 ml in each of the 
portions, and then stored deep frozen till assayed 
Five batches of 3 portions each were thus 
extracted. Each batch was tested in a group of 
3 rats: identical doses were taken from each 
portion, and each rat received one dose from each 
portion, administered in random sequence to avoid 
bias in treatment order. The results were analyse 
as for a 3 x 3 complete block and shown in Table 
12. There was no significant difference between 
-86- 
Table 12 
Reproducibility of the Extraction Procedure of 




Rat No. 1 2 3 Total 
1 3.37 3.7 3.7 10.77 
2 1.8 1.6 1.74 5.14 
3 1.95 1.6 1.45 5.00 
Column 
7.12 6.9 6.89 20.91 Total 
Source Sum of Variance Variance P 
of d.f. Squares Ratio 
Variance 





2 7.1582 3.5791 <.001 
Blocks 
294.1 . 
Error 4 0.0486 0.0122 
Total 8 7.2160 
the responses to the different portions in the 
same batch. 
It will be noted that the results only 
-87- 
indicated that similar proportions of the original 
total activity could be recovered from same amount 
of tissue which were considered to possess the 
same amounts of activity at the start. It was 
assumed that this proportion remained constant 
throughout the subsequent work. The percentage 
recovery of activity remained unknown, though it 
is probably quite high. Quantitative comparison 




QUANTITATIVE STUDIES OF GASTRIN -LIKE ACTIVITY IN 
THE HUMAN GASTRO -INTESTINAL TRACT. 
6. THE DISTRIBUTION OF GASTRIN -LIKE ACTIVITY 
ALONG THE GUT 
6.1 Introduction 
In the study of the topographic distribution 
of gastrin -like activity in the gastro-intestinal 
tract, much attention has been paid to the stomach 
and far less to the rest of the gut. 
Distribution in Animals 
The evidence for the existence of gastrin in 
the antral mucosa of the dog, both on physiologica]r 
and on pharmacological basis, has been reviewed. 
The presence of antral gastrin in other animals 
has been supported, so far, mainly by the demon- 
stration of activity in extracts of the antral 
mucosa. This applies to the hog (Edkins, 1906; 
Uvnäs, 1943, 1945; Munch -Petersen et al., 1944; 
Harper, 1946; Jorpes & Mutt, 1952; Gregory & 
Tracy, 1959, 1960, 1961; Blair et al., 1961; 
Fletcher et al., 1961), cat (Uvnäs, 1943; Blair et 
al., 1961), and the cow and sheep (Fletcher, 1961). 
Edkins (1906) also detected activity in extracts of 
the cardiac mucosa of hogs; this has been confirm- 
ed by Gregory & Tracy (1961). The fundic (or body) 
mucosa was persistently negative in the hands of 
many workers. 
-89- 
Keeton & Koch (191 5) had noted much activity 
in the .pyloric, fundic, and cardiac mucosa of the 
hog, far less in the duodenal mucosa, very small 
amounts in the oesophageal mucosa, and none in 
the pancreas. Since the presence of histamine 
could not be excluded from the extracts with 
certainty, the validity of the positive results 
is to be questioned. However, the negative re- 
sult in the pancreas was probably significant. 
The gastrin content of the stomach wall at 
various depths has also been studied. Lim (1922- 
23) noted that the major part of the activity was 
found in the superficial portion of the pyloric 
mucosa. Blair et al. (1961) have confirmed his 
findings. Baugh et al. (1958) and Baugh (1961), 
by studying the mode of release of gastrin from 
pyloric pouches made from the superficial layer 
of the mucosa only (e.g. down to the muscularis 
mucosae) came to the conclusion that the source of 
gastrin was concentrated in the deeper parts of 
the gastric glands. This is in accordance with 
the suggestion by Redford et al. (1962) based on 
indirect evidence. 
Further down the gut, Sircus (1953) provided 
physiological evidence strongly supporting the 
existence of a hormonal mechanism in the upper 
small intestine which stimulated acid gastric 
-SO- 
secretion. He showed that in a dog distension of 
a duodeno- jejunal loop, amongst other stimuli, led 
to acid secretion from a denervated fundic pouch 
of the stomach, and that this stimulus could be 
nullified by prior procainization of the mucosa of 
the loop. It would appear that the known mechan- 
isms of release and mode of action of this intes- 
tinal hormonal agent are similar to those of gas- 
trin. 
Komarov (1942b) extracted some activity from 
the upper and lower duodenum, a little activity 
from the jejunum, and none from the liver of the 
dog. Uvnäs (1943a) in contrast, could find no 
extractable activity from the duodenal, ileal, 
and colonic mucosa of the dog, cat, and pig. 
Harper (1946) reported activity in the duodenal 
mucosa of the hog. All of the above authors test- 
ed their extracts by intravenous infusion into 
anaesthetized cats. Gregory & Tracy (1961), how- 
ever, could find no activity extractable from hog 
and dog duodenal mucosa, when tested in the con- 
scious dog, though much activity was found in hog 
antral mucosal extracts prepared by the same 
method (which yielded material of high purity and 
therefore minimized possible interference by 
impurities) and tested in the same way. 
Little attention has been paid to the normal 
-91- 
pancreas. Apart from Keeton & Koch (1915), only 
Hallenbeck et al. (1962) reported negative find- 
ings in the pancreas of the dog, hog, and monkey. 
Distribution in Man 
Extracts of the human gastric mucosa have 
been studied by several workers. Lim & Ammon 
(1923 -4) extracted postmortem specimens (12 -63 
hours after death) and found little or no activity, 
though histamine was also probably present in 
their extracts. Ivy & Overhelman (1923 -4) applied 
Keeton & Koch's method (1915) of extraction to 
gastric and duodenal mucosa obtained 1 hour to 
4 days after death and found activity in all ex- 
tracts, the gastric mucosa being approximately 
equipotent with hog antral mucosa, and the duodenal 
mucosa about half of that. Uvnás (1945b) studied 
24 postmortem human stomachs (obtained 10 -36 hours 
after death) using the extraction method of Munch - 
Petersen et al. (1944) and reported considerable 
activity in 14 and slight activity in 4 extracts 
of the antral mucosa; extracts of the body mucosa 
and of the 'Boundary zone' between the body and 
antral mucosa were all negative. Fifteen post- 
mortem specimens of duodenal mucosa were also ex- 
tracted, and only slight activity found in 3, 
Harper et al. (1962), using their own extraction 
-92- 
procedures (Blair et al., 1961), also found 
activity in the antral mucosa obtained soon after 
death. 
No published information is available for the 
gastrin -like activity in the rest of the gut. 
The pancreas has attracted considerable at- 
tention since Zollinger & Ellison (1955) described 
2 patients with pancreatic tumours associated with 
the syndrome which has since been named after them 
Marked hypersecretion of hydrochloric acid from 
the stomach, with its sequel, was a prominent 
feature of the syndrome, and the causal relation- 
ship of the pancreatic tumours was substantiated 
when Gregory et al. (1960) demonstrated extract- 
able gastrin -like activity in one of them. Ample 
confirmation was obtained later. Grossman et al. 
(1961) found activity in the primary pancreatic 
tumour as well as the metastatic deposits in the 
liver of another case of the syndrome. These 
results were confirmed by Code et al. (1962). 
Hallenbeck et al. (1962) reported activity ex- 
tractable from Zollinger -Alison tumours in 8 out 
of 9 cases; of these, 2 were primary tumours and 
the rest metastatic nodules. Three other pan- 
creatic tumours without Zollinger- Ellison syndrome 
were also extracted: 2 produced hypoglycaemia and 
secretion from a Pavlov pouch (vagally innervated) 
-93- 
but not a Heidenhain pouch (vagally denervated) in 
a dog, and the third was negative. Normal pan- 
creatic tissues were also negative. 
6.2 Materials 
Apparently normal tissues, confirmed histo- 
logically, were obtained at various distances alon 
the gut from different patients at operation, and 
were extracted within 30 minutes of their resectio 
by the method of Grossman, Tracy & Gregory (1961) 
as described in Chapter 2. The materials included 
(a) the pancreas, gastric antrum, duodenum, 
and a short segment of the adjacent jejunum 
from one patient in whom Whipple's opera- 
tion was carried out for a localized 
leiomyosarcoma in the second part of the 
duodenum; (Patient A) 
(b) 2 other pieces of pancreas from block dis- 
section during gastrectomy for carcinoma 
of the stomach; (Patients B and C) 
(c) 2 lengths of terminal ileum from a patient 
with endometriosis involving the gut and 
another patient with total colectomy for 
polyposis coli; and (Patients D and E) 
(d) 2 portions of sigmoid colon removed from 
2 patients because of redundancy leading 











































































































































































































































































































































































































The findings are shown in Table 13. It will 
be noted that: 
(a) the highest concentration of gastrin -like 
activity occurred in the antral mucosa, 
(b) there is a clear gradient of concentration 
of activity down the gut, with its maximum 
in the antral mucosa, 
(c) although the unit activity in the duodenal 
mucosa was less than that in the antral 
mucosa, the total extractable activity 
was distinctly greater, and 
(d) the normal pancreas persistently yielded 
no activity. 
The histamine content of all these extracts 
have been estimated in the superfused guinea pig 
ileum preparation (Adam, Hardwick & Spencer, 1954) 
and found to be less than 50 ng /ml of the extract. 
The total volume of the extracts ranged from 
5.5 - 13 ml each, and not more than 1 ml was used 
in each dose during the assay. 
6.4 Discussion and Conclusion 
In Edkins' (1906) original definition, the 
source of gastrin was limited to the gastric 
mucosa. However, the demonstration of gastrin - 
like activity extractable from the mucosa of the 
duodenum and upper jejunum confirmed the findings 
of previous workers and further substantiated the 
physiological evidence for the presence of an 
intestinal phase of gastric secretion. It may 
seem appropriate, then, to expand the definition 
to include the agent from the upper small intest- 
ine which stimulated gastric secretion. 
Since release of the hormonal agent from the 
antrum as well as the small intestine can be 
brought about by similar methods and inhibited by 
similar agents, it is tempting to suggest that the 
upper small intestine could play an important role 
in the physiological control of gastric secretion. 
This does not, however, necessarily mean that the 
active agents from the two sources are identical 
in structure, though their modes of release and 
action may be closely similar. Indeed there are 
apparent discrepancies. Thus the hog duodenal 
mucosa yielded no activity when extracted by a 
method which was highly effective with hog antral 
mucosa (Gregory & Tracy, 1961, Blair et al., 1961) 
and the duodenal mucosa of one animal might give 
active extracts with one method of preparation as 
tested in one animal and be negative with other 
methods of extraction and testing. 
These observed discrepancies could be account 
ed for by one or more of the following possi- 
bilities: 
(a) a difference in behaviour between the con- 
scious and the anaesthetized animal. 
(b) a real difference between gastrin of antral 
and duodenal origin, 
3 
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(c) the presence of impurities in these extracts 
which inhibited gastric secretion in the con- 
scious but not the anaesthetized animal, 
thereby concealing the stimulant effect on 
gastric secretion. 
The answer must await repetition of these 
tests using the Purified agent from the duodenum, 
whether it be gastrin or a gastrin -like substance. 
Experimental evidence suggesting a role of 
the pancreas in the causation of peptic ulceration 
started when Elman & Hartman (1931) observed that 
diversion of the exocrine pancreatic secretion 
away from the duodenum almost invariably led to 
duodenal ulceration. Total pancreateotomy, with 
similar deprivation of the alkaline pancreatic 
juice, however, rarely did so (Dragstedt et al., 
1939). Based on these findings, Poth et al., 
(1948) suspected that the islet tissues might 
produce an endocrine secretion causing peptic 
ulceration. The abundant activity extractable 
from Zollinger -Ellison tumours supports the above 
idea in so far as the pathological pancreas is 
concerned. However, the persistent absence of 
gastrin -like activity in the normal pancreas, in 
confirmation of the findings of Hallenbeck et al. 
(1962), seem difficult to fit in with the postula- 
tion. Whether this is a quantitative or really 
qualitative difference remains to be seen. 
-98- 
Zollinger & McPherson (1958) and Summerskill (1959 
had reported instances where the Zollinger- 
Ellison syndrome occurred in patients in whom the 
pancreas showed hyperplasia of the islets (most 
probably the alpha cells) without any detectable 
neoplasm. Furthermore, Summerskill et al. (1961) 
noted that histologically normal pancreas could 
yield activity when the rest of that same gland 
was studded with multiple adenomata which yielded 
much higher activity when extracted and tested in 
the same manner. These findings could of course 
be interpreted either, (a), that the amount of 
gastrin -like substance produced (if any) by the 
normal number of islet cells could not be detect- 
ed by the methods of extraction and assay used, 
or (b), that the normal pancreas produced no 
gastrin but the factors which (probably) led to 
hyperplasia and neoplasia in these islets also 
conferred upon them the ability to produce a gas- 
trin -like substance. 
Two further points are worthy of note: 
(1) There has been, so far, no positive histo- 
logical identification of the cell type(s) 
in these Zollinger -Ellison tumours (Zollinger 
& Craig, 19605 Chvoyka, 1961), nor real 
proof that they did arise from islet cells, 
apart from morphological resemblances to the 
alpha cells in some of the cases. 
(2) Morphologically, no single type of cells has 
been found common to all the known sites of 
formation of gastrin (or gastrin -like sub- 
stances) in man, viz., the antral and duo- 
denal mucosa and Zollinger- Ellison tumours. 
However, the pannreas shares a common embryo- 
logical origin with the gastro -intestinal 
mucosa in the endodermal lining of the gut 
(Ham & Leeson, 1961, and others). If one 
assumes that gastrin is produced by only one 
type of cells, and that all gastrin -like sub - 
stances are in fact gastrin, then it may be 
that cells from this common embryological 
origin retain their potential ability to 
produce gastrin irrespective of the final 
differentiation. 
The solution to this problem most pro- 
bably lies in a reliable method of identify- 
ing the 'gastrin cell'. The immunological 
approach witizthe fluorescent antibody techniqu 
as suggested by Monaco et al. (1961) may 
prove valuable. 
Little interpretation can be made of the 
presence of gastrin -like activity in the lower gut 
It is perhaps appropriate to re- emphasize that the 
antral and upper small intestinal mucosa are, to 
date, the only sites where the existence of gastri 
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( or gastrin -like substances) is supported by 
physiological evidence. All other active fraction 
are extraction products. This does not exclude 
their existence, but their physiological role has 
not been established. Their positive identifica- 
tionon biochemical grounds in future may add more 
meaning to the present findings. 
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7. THE GASTRIN -LITE ACTIVITY IN THE STOMACHS OF 
PATIENTS WITH PEPTIC ULCERATION AND GASTRIC 
CARCINOMA 
7.1 Introduction 
Little published data is available for the 
contents of gastrin -like activity in the human 
gastro -intestinal tract in disease, due perhaps 
partly to lack of a sensitive and accurate method 
of assay of gastrin. 
Uvnas (1945b) obtained operative specimens 
of stomach from 4 patients with chronic duodenal 
ulcers, 5 with chronic benign gastric ulcers, and 
2 with gastric carcinomata. The gastric mucosa 
was extracted, within 1 -2 hours after resection, 
by the method of Munch -Peterson et al. (1944) and 
assayed in the anaesthetized cat. In 8 out of 
the 9 cases with peptic ulceration and 1 of the 2 
cases of carcinoma, the antral mucosal extracts 
excited marked acid secretion. The body mucosa 
was persistently negative. 
Ferguson (1950) also studied stomachs removed 
at operation from patients with peptic ulceration 
and gastric carcinoma. The pyloric mucosa was 
extracted with boiling N /10 HC1 and the active 
fraction was precipitated by 10% TCA and stored as 
dry powder. Activity was assayed in anaesthetized 
cats with vagotomized isolated stomachs. In this 
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series, there were 15 patients with inactive 
duodenal ulcer, i.e., a typical history, a scarred 
duodenum and usually some pest complication but 
no recent symptoms; 9 had active duodenal ulcer, 
i.e. persistent pain, high acid secretion, and an 
active ulcer with crater; 2 had chronic gastric 
ulcers, 9 had gastric carcinomata, and 2 had 
apparently normal stomachs. The mean unit activit 
of the mucosa (mEq HC1 secreted in one hour by the 
cat /gm mucosa extracted) was similar with the in- 
active D.U's (.029 
± 
.005 standard error) and 
gastric carcinomata (.026 
± 
.01) . Both the gastric 
ulcers and the normals fell within this range. 
The active D.U.'s, however, was about 4 times as 
12 ± large (.  5 .021. Studies on 23 dogs gave 
corresponding values of .022 
± 
.004. These find- 
ings were taken to suggest that hypersecretion 
of acid may be due partly to antral hyperactivity 
in gastrin production. 
The results of the above authors can only be 
taken as roughly quantitative, since the well 
known variation of responses between animals has 
not been overcome, and the pooling of data from 
a group, which was only assumed to be homogeneous, 
in the calculations is not entirely warranted. 
Harper et al. (1962) reported the study on 
the gastrin -like activity in the antral mucosa of 
operative specimens from a series of patients with 
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peptic ulceration and gastric carcinoma. The 
'normal' controls were apparently normal stomachs 
obtained soon after death. The methods for the 
preparation of the extracts and their assay in 
the anaesthetized cat have been reviewed (p.48,26.) 
They showed that the amounts of gastrin -like 
activity extractable from equal portions of hog 
antral mucosa which have been left at room 
temperature for periods up to 22 hours were closel 
similar. This tested the reproducibility of their 
extraction procedure and the stability of gastrin 
in tissues. 
The results on the human material revealed 
that the concentration of gastrin in the antral 
extracts from cases of gastric ulcer is about the 
same as that from normal controls but only about 
half of that from cases with D.U. Extremely low 
unit activity was found in one case of gastric 
carcinoma and one of intestinal metaplasia of the 
antral mucosa. These findings agreed in general 
with those of Ferguson (1950). The body mucosa 
was also negative. 
7.2 Materials 
Partial gastrectomy specimens (Bilroth I or 
Polya operation) from 34 patients were studied, 
comprising 27 with chronic duodenal ulcers, (D.U.) 
3 with benign chronic gastric ulcers, and 4 with 
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gastric carcinomata. All patients had the follow- 
ing tests done before operation: 
(a) The basal secretion - the acid output during 
a one -hour period at 'basal' state. Two or 
more values were obtained from each patient 
and the mean taken. 
(b) The 'Maximal Histamine Output' (Card et al., 
1955) - Histamine phosphate 0.04 mg /kg body 
weight was given subcutaneously under anti- 
histamine cover, and the total acid output 
during the ensuing hour was determined by 
titration to Topfer's reagent. 
In addition, 22 of the patients with duodenal 
ulcers had an Insulin Secretion Test done, the 
total acid output during a two -hour period follow- 
ing an intravenous dose of soluble insulin (0.1 
unit /kg body weight) being taken as the response. 
In all the above tests, continuous aspiration 
of gastric juice was practised. All tests were 
done at least 4 days before operation. 
Duodenal Ulcer Cases 
This group of patients were selected in the 
sense that they all had definite indications for 
surgery, mostly because of complicating stenosis 
in the duodenum or pylorus, and the remainder 
because of persistent dyspepsia or high acid 
secretion. They have been separated into groups, 
as follows: 
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(a) Uncomplicated cases (7 patients) 
(b) Cases with severe stenosis, evidenced by a 
fasting aspirate of 100 ml or more, 
radiological evidence of gross dilation of 
the stomach, and /or operative confirmation 
(5 patients) 
( -c) Cases with severe stenosis and dilated antrum 
as well as the body of the stomach (2 
patients). 
(d) Cases with mild to moderate stenosis, not 
included in the above (10 patients). 
(e) Cases with combined gastric and duodenal 
ulcers (3 patients). All of the gastric 
ulcers were well healed scars in the antrum. 
The reason for this classification will be 
apparent later. 
Gastric Ulcer Cases 
Two of these required surgery because of 
recurrence after medical treatment, and the third 
was operated on for massive haemorrhage from the 
ulcer. 
Gastric Carcinoma Cases 
All were adenocarcinomata. Three were pre - 
pyloric lesions (two ulcerative and the third 
proliferative), and the remaining one in the body 
of the stomach on the greater curvature. 
All specimens of stomach were opened at the 
lesser curvature, washed clean of mucus, and 
divided at the border between the antrum and the 
body. This border could roughly be judged by the 
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naked eye with some accuracy. Occasional strips 
of mucosa at the supposed border were studied 
histologically and all found to be within 0.5 cm 
of the true border. Both antral and body mucosa 
were then stripped, weighed, and extracted 
separately. The final volume of extract from 
each portion was 10 -12 ml. Each extract was 
assayed, and the total gastrin -like activity then 
worked out. Unit activity per gram of mucosa 
was also calculated. 
7.3 Results 
The results are summarized in tables accord- 
ing to their groups (Tables 14 & 15). 
In Fig. 13, the total gastrin -like activity 
extractable per antrum was plotted against the 
'Maximal' histamine output. It will be noted 
that, in general, the contents of gastrin -like 
activity in uncomplicated D.U.'s are smaller than 
those with stenosis, that benign gastric ulcers 
and carcinomata all possess considerable activity 
similaiito or even greater than the average uncom- 
plicated D.U., and that the maximal histamine 
outputs of patients with severe stenosis were 
higher than those of the rest. This last finding 
is in accordance with the results of Hunt & Kay's 
(1954) analysis using Ihre's (1938) data, and 
presumably indicate an increased parietal cell mas 
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TABLE 15 Data from Patients with Benign Gastric Ulcer & Gastric Carcinoia 
Duration Antral Total Patient's Age of Body Pdiucosal Basal Maximal Unit Activity Diagnosis Number (yrs) History Weight Weight Secretion Histamine Activity (pg standard) 
(yrs) (yrs) (gm) (n q /hour) Output (jig standard RA Fiducial 
(mEg /hour) per Gm Tissue) Range (P = .05) .` .X 7533 -- 
.Benign 20K 52 8 64 29 3,5 13 87.3 (81-13) 
Gastric 
Ulcer 21 53 11 45 22.5 0.8 8.25 28.6 
:R 
(711207) 
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65o Pre- pyloric ulcer 
(70- 1355) 
255 Pre -pyloric ulcer 
(75 -127) 
1066 Presented with spastic diplegia for 
(84 -119%) 7 months. Large pre -pyloric ulcer. 
481.5 Ulcer in middle of body of 
(60- -155%) stomach. 
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O Uncomplicated duodenal ulcer 
Duodenal ulcer with moderate stenosis 
X Duodenal ulcer with severe stenosis 
Duodenal ulcer with severe stenosis 
and dilated antrum 
* Duodenal and gastric ulcers 
A Gastric carcinoma 
Benign gastric ulcer 
2 4 6 6 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 
TOTAL GASTRIN - LIKE ACTIVITY ( pg STANDARD X 100 ) 
Fig. 13. Total gastrin -like activity plotted against 
'Maximal Histamine Output'. 
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in the cases with severe stenosis. Both of the 
cases with dilated antra had very low total gas- 
trin -like activity. The cases with combined duo- 
denal and gastric ulcers, however, yielded more 
activity than the average uncomplicated duodenal 
ulcers. 
No definite correlation exists between the 
total activity and maximal histamine output in 
any of the above groups. The same applied to the 
Basal Secretion plotted against the total gastrin - 
like activity (Fig. 14). 
The total gastrin -like activity was also 
plotted against the Insulin -stimulated acid 
secretion (Fig. 15). It may be noted that the 
uncomplicated D.U.'s fell in line with a cor- 
relation coefficient of 0.73, and the slope was 
relatively steep. Also, the acid output of cases 
with severe stenosis were distinctly above the 
less marked ones. This could perhaps be explained 
by their larger parietal cell mass, as shown 
previously. In order to correct for that, the 
insulin -stimulated acid secretion in each case 
was divided by the maximal histamine output, and 
the ratio plotted against the total gastrin -like 
activity. The results as shown in Fig.16 revealed 
that the correlation with the uncomplicated D.U.'s 
was improved (r = .83, P < 0.5), but all the 
stenosed cases now fell into the same zone, and 




































O Uncomplicated duodenal ulcer 
Duodenal ulcer with moderate stenosis 
X Duodenal ulcer with marked stenosis 
Duodenal ulcer with marked stenosis 
and dilated antrum 
* Duodenal and gastric ulcers 
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 
TOTAL GASTRIN - LIKE ACTIVITY (pg STANDARD x 100 ) 
38 40 
Fig. 14. Total gastrin -like activity plotted against 
Basal Secretion expressed as its estimated 
parietal component. 
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O Uncomplicated duodenal ulcer 
A Duodenal ulcer with moderate 
stenosis 
X Duodenal ulcer with severe 
stenosis 
2 4 6 8 1012 141618 2022242628 30 32 34 36 38 40 
TOTAL GASTRIN -LIKE ACTIVITY (,ug STANDARD x 100 ) 
Fig. 15. Total gastrin -like activity plotted against 
Insulin- stimulated Acid Secretion. 
The uncomplicated cases could largely be 
separated from cases with stenosis by 
the dotted line. 
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0 Uncomplicated duodenal ulcer 
X Duodenal ulcer with severe 
stenosis 




0 2 6 8 10 12 14 16 16 20 22 24 26 28 30 32 34 36 38 40 
TOTAL GASTRIN -LIKE ACTIVITY ( »g STANDARD x 100 ) 
Fig. 16. Total gastrin -like activity plotted against 
the Ratio 'Insulin -stimulated Acid Secretion/ 
Maximal Histamine Output'. 
Dotted line: the calculated regression line 
for uncomplicated cases. 
r =0.83 P< .05 
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though the correlation was not significant, the 
trend appeared distinct from the uncomplicated 
cases. It must be admitted that the number of 
uncomplicated cases in this study is small and 
hence sampling error possibly large. But the 
good correlation with or without correction for 
parietal cell mass suggests that they do form a 
separate group. 
There is no correlation between total gastrin - 
like activity or unit activity on the one hand, 
and age and body weight of patient, duration of 
history, or size of the antrum on the other. 
All body mucosal extracts were inactive. 
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7.4 DISCUSSION AND CONCLUSION 
The relatively small number of cases in this 
series, aggravated by the need for further 
division into subgroups, makes interpretation 
difficult. The situation is made worse by a 
number of factors as yet unknown, e.g., the effect 
of anaesthesia and duration of operation on the 
gastrin content, the rate of turnover of gastrin 
and the significance of a single estimate of 
extractable gastrin -like activity. Any comment 
on the above results must therefore be speculat- 
ive. 
There is now good experimental evidence in- 
dicating that vagal excitation stimulates acid 
gastric secretion by (a), causing release of 
gastrin, (b), sensitizing the parietal cells to 
various stimuli including gastrin, and (c), 
direct stimulation of the parietal cell. If one 
assumes that, under strong and possibly maximal 
vagal stimulation by insulin- induced hypoglycaemia 
direct stimulation of the parietal cells is res- 
ponsible for a constant proportion of the acid 
output, then the remainder of the acid secretory 
response to insulin would be accounted for by the 
amount of gastrin liberated. Since, however, 
there is a positive correlation between the 
insulin- stimulated acid secretion and the total 
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gastrin-like activity in the uncomplicated D.U.'s 
in this study, it would seem reasonable to assume 
that, in these cases, the amount of gastrin 
liberated into circulation is proportional to the 
total gastrin -like activity extractable from the 
stomach. This is assumed to be true also for 
D.U.'s with stenosis. 
Hunt & Kay (1954) have suggested that the 
increase in parietal cell mass in D.U.'s with 
stenosis was a result of repeated distension of 
the stomach with consequent stimulation of the 
parietal cells. The data presented in Fig. 15 
and 16 is compatible with this view. The cases 
with stenosis had more gastrin in the antral 
mucosa (and hence probably in the circulation) 
than the uncomplicated cases. The observation 
that cases with mild as well as severe stenosis 
had similar total gastrin -like activity could be 
explained by the possibility of operative inter- 
vention at different phases of progression of the 
disease, it being assumed that a considerable 
time lag exists between the increase in gastrin 
content (and production) and the associated growth 
in the parietal cell mass. 
The results in Fig. 16 indicate that the 
insulin -stimulated secretion per secretory unit, 
represented by the ratio 'insulin- secretion test/ 
maximal histamine output', remained about the same 
despite increase in the total gastrin -like 
activity beyond a point at about the equivalent of 
100 pg of the Standard. This might represent a 
plateau response to maximal or supramaximal levels 
of circulating gastrin. 
The possible role of gastrin in the aetiology 
of duodenal ulceration has been suggested by 
Gillespie & Kay (1961) who showed that antrectomy 
alone led to healing of the duodenal ulcer in 
four patients. The Zollinger -Ellison syndrome 
provides an extreme example of possible effects of 
excessive gastrin (or gastrin -like substance) in 
circulation. The idea of gastrin possibly playing 
a role as a trophic hormone to the parietal cells 
has been summarized by Card (1962), who cited in 
support a case of Zollinger -Ellison syndrome of 
Dr. Bryan Alton when the 'maximal histamine output' 
of the patient progressively fell after partial 
resection of the pancreas and left adrenalectomy 
without any surgery on the stomach. The failure 
to demonstrate a correlation between the 'maximal 
histamine output' and gastrin -like activity in 
this present study does not support this idea but 
certainly does not exclude it, since apart from 
all the unknown factors mentioned above, this 
series could well have included cases with a large 
parietal cell mass to start with, irrespective of 
the gastrin content in the antrum. 
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The whole problem of the clinical signi- 
ficance of gastrin is obviously a dynamic one, 
a better approach to which would probably be the 
assay of gastrin in blood or urine, methods for 
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APPENDIX II. Preparation of Gastrin (Gregory & 
Tracy, 1961). 
Stage I. Fresh hog stomachs from abbatoir (fixed 
(a) in 5011 aq. TCA) 
1 kgm of mucosa stripped in narrow pieces 
J, 
Add 2 L of 4% TCA in 90% acetone. Stand 
overnight (room temperature) 
Filter through fluted paper (Green 9041 ) 
(b) Filtrate + 10 ml 10N HCl. Extract once 
with 2 vol. & 3 times with 1 vol. of 
ether. 
(e) 
Aqueous phase (volume x ml) + 2N NaOH 
till pH 3. Warm to expel ether. 
Heat to 70 -80 °C. Add 2N NaOH till pH 
5 -5.5; copious ppt. Leave 10 min. 
Add NH3 solution (0.88 NH3 solution + 
equal vol HO) till pH 8.5. Leave 5 min. 
Cool 
Centrifuge 5 min. (about 500 G). 
A.. 
Supernatant 
(golden yellow, clear) 
+ 10N HCl till pH 4.5 
Residue + 0.1 NHC1 (x 
warm to 70 °C. 
Partial solution. Lea e 
5 -10 min. 
+ 20 vol. of 30% NaC1 
solution 
+ 2N NaOH till pH 5 -5.5; 
leave 10 min. 
J, 
+ dil. NH3 solution til 
pH 8.5; leave 10 min. 
cool, centrifuge 5 mi 
(500G) 
Supernatant Residue 
+ 1ON HC1 till discard -d 
pH 4.5 
(d) Add NaCl crystals to final concentration 
of 30%, with constant stirring. Floc- 
culent precipitate formed. Stand 60 
min. at room temperature. 
Filter through coarse paper (Green 904) 
suction with aid of 2G acid -washed hyfl 
supercel. ?,Nash cake with 30% NaCl, the 
suck dry. 
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(e) Resuspend cake in 100 ml 0.1 N HC1, and re- 
peat precipitation at pH 5 -5.5 and 8.5 as 
in (c) above. 
Combined supernatant + 10N HC1 till pH 7. 
Cool to 100C. (Vol. y cc.) 
(f) Add TCA crystals (to give final concentratio 
of 4% in solution), dissolved in 20 ml dis- 
tilled water, drop by drop (over 15 minutes 
with constant stirring. 
Heavy white precipitate formed. Stand in 
refrigerator for 45 min. 
Centrifuge 10 min. (500 G) 
Supernatant discarded. Dry inside of cup. 
Residue + y cc distilled water. Warm 
gently. Green solution. 
Cool to 10 °C and repeat TCA precipitation a 
in (f) above. 
(h) Residue + 100 ml acetone slowly. Green 
viscid solution formed first, then heavy 
flocculent precipitate. 
+ 10 N HC1 slowly (2 ml /100 ml acetone). 
Shake well. 
+ ether till cup full (about 100 ml). Shake 
well. Stand 5 min. Centrifuge. 
Supernatant discarded. Gummy precipitation 
resuspended finely in acetone. Centrifuge. 
1 
Supernatant removed by suction. Precipitat 
shaken up with ether. Centrifuge. 
1 
Ether sucked off. Residue left in cup over- 
night. Dry powder collected next morning 
and weighed and stored in the dark. 
(g) 
Usual yield: 600 -700 mg/kgm mucosa. 
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APPENDIX II. Preparation of Gastrin (Gregory & 
Tracy, 1961) Continued. 
Stage II. 
600 mg of Stage I powder dissolved in 30 ml 
distilled water (may warm gently to aid 
solution but cool before proceeding). 
+ 2N NaOH slowly till pH 5 -5.5; flocculent 
precipitate formed. 
+ few drops of piperidine till pH 10 -10.5; 
perfectly clear green solution. 
1 
+ 120 ml acetone slowly, with stirring. Curdy 
precipitate with cloudy supernatant. 
+ Dilute acetic acid slowly till pH 8.5 
Pour into dry centrifuge, shake vigorously, 
stand a few minutes, centrifuge briefly 
Clear supernatant 




+ 20 ml dist. 




Residue + 30 ml dist. 
H2O 
+ 1 -2 drops piperidine. 
Clear solution 
Pour into original bea er. 
+ 0.1 ml 30% NaC1 soin 
+ 120 ml acetone slowl 
with stirring 
+ dil. acetic acid til 
pH 8.5 
1 
Shake in centrifuge cu 
Stand a few min. Cen- 
trifuge 5 min. 
Clear Residue 
Supernatant discard -d 
+ 600 ml ether, shake, stand 
Aqueous Ethereal phase 
phase H20. Shake, s 
Aqueous phase 
+ 20 ml. dist 
and a few min. 
Re- extract twice with 2 -3 volumes of ether. 
Stand overnight in wide dish in dark cupboard 
at room temperature. 
Solution clear, faintly pigmented, with pH of bout 7. 
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Stage III. 
Calcium phosphate gel was prepared by slowly 
mixing equal volumes of 0.5 molar CaC12 and 0.5 
molar Na2HPO4, boiling the mixture for an hour, 
and washing the precipitate with distilled H2O 
till the pH was ̀ 10. Before use, the pH of the gel 
was adjusted to 7 by dilute acetic acid. A column 
was made with the gel, measuring 3 -4 cm long and 
15 -20 mm diameter. 
Stage II solution run on to column at 25 ml/h r 
Column washed with 50 ml dist. water at 40 ml /hr. 
Elution of column with Na HP0 (0.07% anhydrous 
salt) at 10 ml/hour. Mott of the activity 
usually eluted in the first 20 ml. 
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APPENDIX III. Preparation of Crude Gastrin Extrac 
(Grossman, Tracy & Gregory, 1961) 
Mucosa (or pancreatic tissue) cleaned, weighed, 
and cut in small pieces (-in. x 4- in.) 
Immerse in 10 vol. of 4% TCA in 90% acetone. 
Stand overnight at room temperature, with 
occasional stirring. Drain. 
Supernatant Tissue re- extracted twice 




Add lO N HCI ( 5 ml /litre of extract) 
Extract once with 2 vol. and 3 times with 1 vol. 
of ether 
+ 2N NaOH till pH 3. Warm in bath at 70 °C to 
expel ether. Measure volume of extract. 
Cool to 10 °C. Carry out twice TCA precipitation as 
in Stage I procedure (f) & (g) in Appendix I. 
Precipitate + convenient volume of 0.15N HC1 
(about 1 ml/2 -4 gm wet weight of mucosa) 
Extract once with 2 vol. and 3 times with 1 vol. o 
ether. 
1 
+ 2N NaOH till pH 3. Warm to expel ether. 
Heat to 70- 800C. Add 2N NaOH till pH 5.5; dense 
ppt. Leave 101 min. 
+ NH3 solution (0.88 NH3 solution diluted 10 times 
till pH 8.5' leave 10 min. Cool. Centrifuge 10 
min. (500 G) . 
1 
Clear supernatant. Volume measured. Stored in 
deep freeze till assayed. 
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APPENDIX IV (a) (1) 
Analysis of Variance for the Balanced Incomplete 
Block 
Dose Order Block 
Rat Number 1st 
2nd 3rd Total 
1 LS1 HS1 LT1 B1 
2 LT2 HT2 LS2 B2 
3 HS3 LT3 HT3 B3 
4 HT4 LS4 HS4 B4 
Column Total Ca Cb Cc G 
Dose Block 
HS LS HT LT Total 
Rat Number 
1 HS. LS1 LT1 B1 
2 LS2 HT2 LT2 B2 
3 HS3 HT3 LT3 B3 
4 HS4 LS4 HT4 B4 
Column Total VHS VLS VHT VLT G 
t = number of different treatments (e.g. 
HST LS, HT, LT) 
k = number of doses per block 
r = number of replicates (i.e. number of 
times each treatment appears in the 





number of blocks (i.e. number of rats) 
tr = bk 
grand total of all treatments within a 
balanced group. 
r(k - 1) 
t - 
V.....total for lth treatment within a balanc- 
ed group (e.g. VLS= LS1+ LS2 + LS4) 
F correction factor. 
2 
(A) For Columns (i.e. for effect of dose order) 
C G2 Sum of squares (s.s.) = k - Ñ 
(B) For Blocks (ignoringtreatments i.e. Interbl 
Variation3 
Sum of Squares = B G2 b - N 
Ti = sum of block totals containing ith 
treatment (e.g. TLS = B1 +B2 +B4) 
Interblock Treatment Component 
(T-T2 
s.s. = k(t - x 
= 
k(fi 
-X) [2T2 - 
(IT)2/t] 
= k(tl4.) [2'T2 - (kG)2/t' 
Partition of s.s. 
Z aT 
4k(t-X) 
= (Li )2 = (-TLS + THS - T4T + THr 
S.S. 
Regression 





s.s. 7.77=K) = 
Preparation (Lp) 
2 
( TL5 - THS - TLr + THr 
4k(t- X 
(TLS - THS + TLT + THT 
s.s. - 4k(t-?.) - 4k t - X 
(C) For Treatments (eliminating blocks, i.e. 
error depending on variation within rats 
only). 
For each treatment, Qi = kVi - 2- Bi 
where B1= sum of block totals over blocks 
r containing i -th treatment 
(e.g. B 
LS 
B1 +B2 +B4) 
Sum of squares = 
t-1 27 Q2 
Nk(k -1) 
Partition of the s.s. 
Regression (t- 
1)(Lí)2 
s.s. 4Nk(k -1) 
Parallelism (t- 
1)(L4)2 
s.s - 4Nk(k-1) 
Preparation 
(t -1)(L )2 
S.s. - 4Nk(k -1) 
where Li = -QLS + QHS - 
H 
It 
Lr= QLs - QHs- LT + QHr 
LT Q HT 
L =-QLS - Q + Q HT 
(D) Total sum of squares = (y - ÿ)2 
_ ßy2 G2 
- N 
Potency Ratio 
The standard was expressed in actual weight 
material in the dose (viz. HS = 11 µg). The test 
preparation was expressed in the volume used in 
the dose (viz. HT = 0.0075 ml) 
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D = dose interval 
Z5 










log D) in 
Fid.ucial Limits 
In general, Feiller's Theorem (Feiner, 1944; 
Finney, 1952) gives the fiducial limits (F.L.) of 
a ratio, say, m = b, as 
¡ 2 F.L. of m = - ( -) Vzz (/ ) JV l -m V2 +ín2.1/21 vi - 2 
where Var( a) = v11s2, Var(b) = vz2s2, and Cov(a,b) = va s 2. 
If v12 s2 = 0, then 
F.L. of m = + mZ Vzz (2) 
Also, if a is represented by (ÿ7- - s ), then 
(Yr - Ys ) 
m = - M - (xs - xT ), where M = log R . . . (3) 
Substituting equation in (2): 
Xj 
M-(X5-xT, s 
) f (l-XSfXT)ZV2Z . . (4) F.L. of M- xs- i - l/i 
For this assay, v11 = N(k -1) V22- 4 x N(k -1) 
g 
b 
t 2 s Zvz.,. 
b2 
2 (x-X)(3r-Y) 
Since 2 (x -.x) (y -) = 1Y(x -x) = 2 yN = n(YH - Y ) 
and, in this assay, ¿(x - x)2 = N, and n = 2 
-124- 
b- 2 N(YH - yc ) = 5-115+ yHr - jTCS - Ycr 
. . - 
N 4 
Substituting ÿ. = t- 1 G 
1 N(k - 1) i N 9 
t- 1 QHs+ QHT- (1.5- QLT (t - 1) x Li b-N(k-1)x 4 -PT(k-])x4 
t- 1 Q MT + 6T Q Hs + Q LSl 
(Yr - s ) Corr. - - N(k - 1) x t/2 t/2 
2Lp 
N(k-1 ) x 
3Tr - Ys 2Lp 4 2Lp 
M -(xs- )7T) = b - L i 
since t = 4 . 
Substituting equation (6) to (1): 
Z5 
R = Tr- antilog {(M - (5E-5- xr )) x log 5 
[ 
Zs 
= antilog log 
(-J7-7T 
+ {(M - (5E5- R-7-)) x flog D} 
fiog F.L. of R = a.ntilog ET- + (R.H.S. of eq. (4) 
. (5) 
. (6) 
) x log D . 
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APPENDIX IV (b) Analysis of Single Block of 

















12.95 13.09 14.23 40.27 
VLS = 8.82 t = .4 
VHS = 13.57 k = 3 
VLT = 6.43. r = 3 
VHT = 11.45 b = 4 




13 5.1394 = t-1 = 2 
Between Columns s.s. 
12.952 + 13.092 + 14.232 
4 
- 135.1394 = 0.24647 
Between Blocks s.s. 
8.812 + 8.652 + 11.332 + 11.482 135.1394 
3 
= 2.39323 
Between Treatments (Intrablock 
QLS = (3 x 8.82) - (8.81 + 8.65 + 11.48) _ - 2.48 
QNS = (3 x 13.57) - (8.81 + 11.33) + 11.48) = 9.09 
Qhr = (3 x 6.43) - (8.81 + 8.65 + 11.33) =-9.50 
QHT = (3 x 11.45) - (8.65 + 11.33 + 11.48) = 2.89 
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1) Regression: LI 







Check : 5.98 + 1.8205 + O.007 = 7.8075 
2 




HS = 11 µg HT = 0.0075 ml ) of same solution 
LS = 5.5m LT = 0.00375 ml) (1100 µg/ml ) 




antilog (L- log10D) -.0075 antilog( 
-2 3 92 
= 1000.56 µg /ml. 
Corrected Means Cf. Uncorrected Means 
HS = N k -l)QHS 
+ 
Ñ = 4.492 
13351 = 4.523 
HT = 3.717 
LS = 3.046 
LT = 2.169 





























































































































































































































































































































































































































































k(t-1) 1 k(t-1) L1 
vil 1T(k-1) - v22 - 4 AT(k-1) - 32 b = 32 = 0. 487 
s2 = 0.062 with 5 d.f. t(P = 0.95, 5 d.f.) = 2.571 
2 




.°. 1 - g = 0.9294 
2LP M 
(xS - XT ) = L 
1 
s = s = 0.2490 




= log 1467 = 3.1662 
TT 
F.L. of ("! -'ÿ )/b - -1.1035 + 0.2490 x 2.571 
T S - 0.9294 0.7487 x 0.9294 
(0.9294 x i) + (1.1035)2 
= -1.8131, -0.5615 
p°. Upper Fiducial limit of R = antilog(3.1662 -(0.5615x0.1505)) 
=1207 
Lower Fiducial limit of R = antilog(3.1662 -(1.81310.1505)) 
= 782. 
Result: Potency estimated as 1000.6 p,g /ml 
Fiducial limits of estimate (P = 0.95) 
= 782.2 - 1207 µg /ml 
= -21.8% to +20.6% of estimate 
Actual potency = 1100 µg /ml 
Fiducial limits in terms of actual potency 
= -28.9% to +9.7% 
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APPENDIX IV (c) Analysis of a Block with 12 Rats 
(Blocks No. 1 + 2 + 3) 
Gastrin Assay (1), (2) & (3) analysed as Single 
t = 4 
k = 3 
r = 9 
b = 12 
12 Block Assay 
N = 36 
X = 6 
G = 94.13 
Ç = 246.1238 
Between Columns s.s. - 30.372 
VLS = 19.865 
VHS = 31.53 
VLT = 16.87 
VHT = ?5.ß65 
+ 31.1112 + 32.322 
12 
- 246.1238 = 0.1589 
Between Blocks s.s. = (137.53263 + 82.1266 + 45.4 
- 246.1238 = 19,002 
Interblock Treatment Component: 
TLS = 69.65 TLT = 70.115 
THS = 72.855 THT = 69.77 
Check : 27T = kG = 282.39 
2 
g.g. - [T2 9 k(r -1) - S tT = 0.767; 
Partition of Interblock Treatment Component: 
1) Regression: L1 = 2.86 s.s. = 0.2272 
2) Parallelism: L1'= 3.55 s.s. = 0.3500 
3) Preparation: L = -2.62 s.s. = 0.1906 
Check: 0.19067 + 0.35007 + 0.2272 = 0.7679 
Intrablock Treatment: 
QLS = -10.055 QLT = 
-19.505 
QHS 
= 21.735 QHT = 7.825 




Partition of Intrablock Treatment s.s.: 
1) Regression: L1 = 59.12 
2) Parallelism: Ll° = -4.46 
3) Preparation: Lp = -23.36 
S.S. = 12.1360 
s.s. = 0.0690 
s.s. = 1.8948 
Check : 12.13602 + 0.069068 + 1.89475 = 14.0998 
Total s.s. = (145.6467 + 85.3746 + 49.7794) - 246.1'38 
= 34.6769 




b - 59.12 0.6158 
- 32x3 
= 1115.4 µg/m1 
1 
V11 = $ V = - 32 
s2 = 0.07504 with 21 d.f. t(P = .95, 21 d.f.l = 2.08 
22 








.'. F.L. of M - (xs - xT) 
-0.79025 + 0.27295x2.08 gizal 
= 0.9731 - 0.6158x0.9731 
= - 0.8121 
± 
0.35723 
= - 0.45485 - 1.1693 
(0.79025) 
Upper F.L. of R = antilog(3.1662 - (0.4549 x .150 
= 1252µg /m1. 
Lower 11 = antilog(3.1662 - (1.1693 x 0.1 







































































































































































































































































































































































































































































































































































































































Results: Estimated Potency = 1115.4 µg /m1 (1.4% hi 
Fiducial Limits(P =.95) = 977.9 - 1252 
= -12.3% to + 12.3% of 
Estimated potency. 
Corrected means: HS = 3.52 LS = 2.195 
vs. Uncorrected 3.503 2.207 
Corrected means: HT = 2.94 LT = 1.80 
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